Publicaciones GENVIP (Genética, Vacunas, Infecciones y Pediatría)

• Cook A, Sharland M, Yau Y; PediBSIGroup*, Bielicki J. (Martinón-Torres F)
IMPROVING EMPIRIC ANTIBIOTIC PRESCRIBING IN PEDIATRIC BLOODSTREAM INFECTIONS: A POTENTIAL APPLICATION OF WEIGHTED-INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAMS (WISCA)
Expert Rev Anti InfectTher. 2022 Mar;20(3):445-456
A – Factor Impacto JCR: 5.091- Q1- Infectious Diseases

• Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Environ Res. 2022 Mar;204(Pt A):111909. Epub 2021 Aug 20
A – Factor de impacto JCR:6.498- Q1 – EnvironmentalSciences

• Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, García-García B, González-Iglesias I, Alonso-Penanes P, González-Guerrero M, Gutiérrez-Palacios A, Miranda-Martínez E, Martinón-Torres F
VESICULOBULLOUS SKIN REACTIONS INDUCED BY COVID-19 MRNA VACCINE: REPORT OF FOUR CASES AND REVIEW OF THE LITERATURE
Clin ExpDermatol. 2022 Jan;47(1):141-143. Epub 2021 Sep 2
A – Factor de impacto JCR: 3.47- Q2- Dermatology

• Hagedoorn NN, Zachariasse JM, Borensztajn D, Adriaansens E, vonBoth U, Carrol ED, Eleftheriou I, Emonts M, van derFlier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA; PERFORM consortium (Martinón-Torres F)
SHOCK INDEX IN THE EARLY ASSESSMENT OF FEBRILE CHILDREN AT THE EMERGENCY
ArchDis Child. 2022 Feb;107(2):116-122. Epub 2021 Jun 22
A – Factor Impacto JCR: 3.801- Q1- Pediatrics

• Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW Jr, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. (Martinón-Torres F)
EVALUATION OF THE BNT162B2 COVID-19 VACCINE IN CHILDREN 5 TO 11 YEARS OF AGE
N Engl J Med. 2022 Jan 6;386(1):35-46
A – Factor Impacto JCR: 91,253- Q1- D1- General & Internal Medicine

• Martinón-Torres F, González-Barcala FJ.
WHERE IS RESPIRATORY SYNCYTIAL VIRUS HIDDEN?
DONDE SE ESCONDE EL VIRUS RESPIRATORIO SINCITIAL?
ArchBronconeumol. 2021 Jun 18.
A – Factor Impacto JCR: 4.872- Q2- Archivos de bronconeumología

• Zeevat F, Luttjeboer J, Paulissen JHJ, van derSchans J, Beutels P, Boersma C, Postma MJ; RESCEU Investigators. (Martinón-Torres F)
EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF A HYPOTHETICAL RSV VACCINE FOR OLDER ADULTS IN THE NETHERLANDS AND THE UNITED KINGDOM
J InfectDis. 2021 Sep 15;jiab118.
A – Factor Impacto JCR: 5,022- Q1- Medicine

• Shi T, Vennard S, Jasiewicz F, Brogden R, Nair H; RESCEU Investigators. (Martinón-Torres F)
DISEASE BURDEN ESTIMATES OF RESPIRATORY SYNCYTIAL VIRUS RELATED ACUTE RESPIRATORY INFECTIONS IN ADULTS WITH COMORBIDITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
J InfectDis. 2021 Sep 15;jiab040.
A – Factor Impacto JCR: 5,022- Q1- Medicine

• McGinley J, Thwaites R, Brebner W, Greenan-Barrett L, Aerssens J, Öner D, Bont L, Wildenbeest J, Martinón-Torres F, Nair H, Pollard AJ, Openshaw P, Drysdale S; REspiratorySyncytial virus Consortium in EUrope (RESCEU) Investigators.
A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANIMAL STUDIES INVESTIGATING THE RELATIONSHIP BETWEEN SERUM ANTIBODY, T LYMPHOCYTES, AND RESPIRATORY SYNCYTIAL VIRUS DISEASE
J InfectDis. 2021 Sep 15;jiab370
A – Factor Impacto JCR: 5,022- Q1- Medicine

• Martinón-Torres F, Taha MK, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V
EVOLVING STRATEGIES FOR MENINGOCOCCAL VACCINATION IN EUROPE: OVERVIEW AND KEY DETERMINANTS FOR CURRENT AND FUTURE CONSIDERATIONS
PathogGlobHealth. 2021 Sep 27;1-14.
A – Factor de impacto JCR: 2.894- Q2- Parasitology

• Korsten K, Adriaenssens N, Coenen S, Butler CC, Verheij TJM, Bont LJ, Wildenbeest JG; RESCEU Investigators. (Martinón-Torres F)
WORLD HEALTH ORGANIZATION INFLUENZA-LIKE ILLNESS UNDERESTIMATES THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN COMMUNITY-DWELLING OLDER ADULTS.
J InfectDis. 2021 Dec 14:jiab452.
A – Factor Impacto JCR: 5,022- Q1- Medicine

• Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
CORRIGENDUM: CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEOUS HETEROPLASIA
Front Pediatr. 2021 Dec 14; 9: 807812.
A – Factor Impacto JCR: 3.418- Q1- Pediatrics

• Mantha OL, Flamein F, Turner MA, Fernandes RM, Hankard R; Network ofNational Networks StudyGroup. (Martinón-Torres F)
EARLY IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ON PEDIATRIC CLINICAL RESEARCH: A PAN-EUROPEAN AND CANADIAN SNAPSHOT IN TIME.
J Pediatr. 2021 Dec;239:67-73.e3. Epub 2021 aug 23
A – Factor Impacto JCR: 4.406- Q1- Pediatrics

• O’Connor D, Moschese V, Martinon-Torres F, Palma P.
EDITORIAL: VACCINATION OF SPECIAL POPULATIONS: PROTECTING THE VULNERABLE.
Front Immunol. 2021 Dec 6;12:815550.
A – Factor de impacto JCR:7.561- Q1 – Immunology

• Martinón-Torres F, García-Sastre A, Pollard AJ, Martín C, Osterhaus A, Ladhani SN, Ramilo O, Gómez Rial J, Salas A, Bosch FX, Martinón-Torres M, Mina MJ, Cherry J
TIPICO XI: REPORT OF THE FIRST SERIES AND PODCAST ON INFECTIOUS DISEASES AND VACCINES (ATIPICO)
Hum VaccinImmunother. 2021 Nov 11;1-29
A – Factor Impacto JCR: 3,452- Q2- Biotechnology & Applied Microbiology

• Boeddha NP, Driessen GJ, Hagedoorn NN, Kohlfuerst DS, Hoggart CJ, van Rijswijk AL, Ekinci E, Priem D, Schlapbach LJ, Herberg JA, de Groot R, Anderson ST, Fink CG, Carrol ED, van derFlier M, Martinón-Torres F, Levin M, Leebeek FW, Zenz W, de Maat MPM, Hazelzet JA, Emonts M, Dik WA.
DETECTABLE A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS-1 IN SERUM IS ASSOCIATED WITH ADVERSE OUTCOME IN PEDIATRIC SEPSIS
Crit Care Explor. 2021 Nov 8;3(11):e0569
A – Factor Impacto JCR: 9.097- Q1- Critical Care Medicine

• Mosina L, Külper-Schiek W, Jacques-Carroll L, Earnshaw A, Harder T, Martinón-Torres F, Wilder-Smith A, Wichmann O, Datta SS
SUPPORTING NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUPS IN THE WHO EUROPEAN REGION IN DEVELOPING NATIONAL COVID-19 VACCINATION RECOMMENDATIONS THROUGH ONLINE COMMUNICATION PLATFORM
Vaccine. 2021 Oct 29;39(45):6595-6600.Epub 2021 Sep 16.
A – Factor Impacto JCR: 3.641- Q3- Immunology

• Lin GL, Drysdale SB, Snape MD, O’Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
PUBLISHER CORRECTION: DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
NatCommun. 2021 Oct 7;12(1):5971.
A – Factor Impacto JCR: 14.919- Q1- D1- Multidisciplinary Sciences

• Gómez-Carballa A, Pardo-Seco J, Bello X, Martinón-Torres F, Salas A.
SUPERSPREADING IN THE EMERGENCE OF COVID-19 VARIANTS
Trends Genet. 2021 Dec;37(12):1069-1080. Epub 2021 Sep 8.
A – Factor de impacto JCR: 11.639- Q1- D1- Genetics & Heredity

• Martinón-Torres F, Bertrand-Gerentes I, Oster P.
A NOVEL VACCINE TO PREVENT MENINGOCOCCAL DISEASE BEYOND THE FIRST YEAR OF LIFE: AN EARLY REVIEW OF MENACYW-TT
Expert RevVaccines .2021 Sep;20(9):1123-1146. Epub 2021 Sep 1.
A – Factor de impacto JCR: 5.217 – Q2- Immunology

• Navarro L, Martinón-Torres F, Salas A
SENSOGENOMICS AND THE BIOLOGICAL BACKGROUND UNDERLYING MUSICAL STIMULI: PERSPECTIVES FOR A NEW ERA OF MUSICAL RESEARCH
Genes (Basel). 2021 Sep 21;12(9):1454
A – Factor de impacto JCR:4.096- Q2- Genetics&Heredity

• Borensztajn DM, Hagedoorn NN, Carrol ED, vonBoth U, Dewez JE, Emonts M, van derFlier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Maconochie IK, Martinon-Torres F, Nieboer D, Nijman RG, Oostenbrink R, Pokorn M, Calle IR, Strle F, Tsolia M, Vermont CL, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: PersonalisedRiskassessment in febrilechildrentooptimise Real-life Management acrosstheEuropeanUnion. (Martinón-Torres F)
A NICE COMBINATION FOR PREDICTING HOSPITALISATION AT THE EMERGENCY DEPARTMENT: A EUROPEAN MULTICENTRE OBSERVATIONAL STUDY OF FEBRILE CHILDREN
Lancet RegHealthEur. 2021 Jul 12;8:100173. eCollection 2021 Sep
A – Factor de impacto JCR:19.173- Q1 – D1- EnvironmentalSciences

• Lin GL, Drysdale SB, Snape MD, O’Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
NatCommun. 2021 Aug 26;12(1):5125.
A – Factor de impacto JCR:14.919- Q1 – D1- MultidisciplinarySciences

• Esposito S, Abu-Raya B, Bonanni P, Cahn-Sellem F, Flanagan KL, Martinon Torres F, Mejias A, Nadel S, Safadi MAP, Simon A
COADMINISTRATION OF ANTI-VIRAL MONOCLONAL ANTIBODIES WITH ROUTINE PEDIATRIC VACCINES AND IMPLICATIONS FOR NIRSEVIMAB USE: A WHITE PAPER
Front Immunol. 2021 Aug 11;12:708939.
A – Factor de impacto JCR:7.561- Q1 – Immunology

• Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Donà D, Matheeussen V, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, NyirendaNyang’wa M, Keers S, Renk H, Gemmel AL, D’Amore C, CiofiDegliAtti M, Rodríguez-Tenreiro Sánchez C, Martinón-Torres F, Burokienė S, Goetghebuer T, Spoulou V, Riordan A, Calvo C, Gkentzi D, Hufnagel M, Openshaw PJ, de Jong MD, Koopmans M, Goossens H, Ieven M, Fraaij PLA, Giaquinto C, Bielicki JA, Horby P, Sharland M.
AETIOLOGY OF ACUTE RESPIRATORY INFECTION IN PRESCHOOL CHILDREN REQUIRING HOSPITALISATION IN EUROPE-RESULTS FROM THE PED-MERMAIDS MULTICENTRE CASE-CONTROL STUDY
BMJ Open Respir Res. 2021 Jul;8(1):e000887
A – Factor de impacto JCR:2.692- Q2 – Medicine, General &internal -SCIE

• Nijman RG, Oostenbrink R, Moll HA, Casals-Pascual C, vonBoth U, Cunnington A, De T, Eleftheriou I, Emonts M, Fink C, van derFlier M, de Groot R, Kaforou M, Kohlmaier B, Kuijpers TW, Lim E, Maconochie IK, Paulus S, Martinon-Torres F, Pokorn M, Romaine ST, Calle IR, Schlapbach LJ, Smit FJ, Tsolia M, Usuf E, Wright VJ, Yeung S, Zavadska D, Zenz W, Levin M, Herberg JA, Carrol ED; PERFORM consortium (PersonalizedRiskassessment in febrilechildrentooptimize Real-life Management acrosstheEuropeanUnion).
A NOVEL FRAMEWORK FOR PHENOTYPING CHILDREN WITH SUSPECTED OR CONFIRMED INFECTION FOR FUTURE BIOMARKER STUDIES
Front Pediatr. 2021 Jul 28;9:688272
A – Factor de impacto JCR:3.418- Q1 – Pediatrics

• Nyaku M, Richardson E, Martinon-Torres F, Kuter BJ
EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF M-M-RII (COMBINATION MEASLES-MUMPS-RUBELLA VACCINE): CLINICAL TRIALS OF HEALTHY CHILDREN AND ADULTS PUBLISHED BETWEEN 2010 AND 2019
PediatrInfectDis J. 2021 Nov 1;40(11):1046-1054
A – Factor de impacto JCR:2.129- Q3- Pediatrics

• Safadi MAP, Martinón-Torres F, Serra L, Burman C, Presa J.
TRANSLATING MENINGOCOCCAL SEROGROUP B VACCINES FOR HEALTHCARE PROFESSIONALS
Expert RevVaccines. 2021 Apr 3;20(4):401-414. Epub 2021 Jun 20.
A – Factor de impacto JCR: 5.217- Q2- Immunology

• Barrios-Tascón A, Miura M, Domínguez-Rodríguez S, Fernández-Cooke E, Sarquella-Brugada G, Tagarro A; KAWA-RACE studygroup, (Martinón-Torres F)
VENTRICULAR REPOLARIZATION PARAMETERS AND CORONARY INVOLVEMENT IN KAWASAKI DISEASE
J Pediatr. 2021 Sep; 236:108-112.e5. Epub 2021 May 15
A – Factor Impacto JCR: 4.406- Q1- Pediatrics

• Martínez-Planas A, Baquero-Artigao F, Santiago B, Fortuny C, Méndez-Echevarría A, Del Rosal T, Bustillo-Alonso M, Gale I, Guerrero C, Blázquez-Gamero D, Canet A, Lillo M, Calavia O, Núñez Cuadros E, Falcón-Neyra L, Soriano-Arandes A, Van Ingen J, Tebruegge M, Noguera-Julian A; SpanishPediatric TB Research Network (pTBred) and theEuropeanNontuberculouSMycoBacterialLymphadenitis in childrEn (ENSeMBLE) Study. (Martinón-Torres F)
INTERFERON-GAMMA RELEASE ASSAYS DIFFERENTIATE BETWEEN MYCOBACTERIUM AVIUM COMPLEX AND TUBERCULOUS LYMPHADENITIS IN CHILDREN
J Pediatr. 2021 Sep; 236:211-218.e2. Epub 2021 May 10
A – Factor Impacto JCR: 4.406- Q1- Pediatrics

• Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEUS HETEROPLASIA
Front Pediatr. 2021 Jun 23; 9: 662669
A – Factor Impacto JCR: 3.418- Q1- Pediatrics

• McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, Broderick C, Nijman R, Tremoulet AH, Munblit D, Ulloa-Gutierrez R, Carter MJ, De T, Hoggart C, Whittaker E, Herberg JA, Kaforou M, Cunnington AJ, Levin M; BATS Consortium; (Martinón-Torres Federico)
TREATMENT OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
N Engl J Med. 2021 Jul 1;385(1):11-22.
A – Factor Impacto JCR: 91.253- Q1- D1- Medicine, General & Internal

• Hagedoorn NN, Borensztajn D, Nijman RG, Nieboer D, Herberg JA, Balode A, vonBoth U, Carrol E, Eleftheriou I, Emonts M, van derFlier M, de Groot R, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Pokorn M, Strle F, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INVASIVE BACTERIAL INFECTIONS IN FEBRILE CHILDREN AT EUROPEAN EMERGENCY DEPARTMENTS: MOFICHE, A PROSPECTIVE OBSERVATIONAL STUDY
ArchDis Child. 2021 Jul;106(7):641-647.
A – Factor Impacto JCR: 3.801- Q1- Pediatrics

• Schaffner, T. O.; Martinon-Torres F; Banzhoff, A; Azzari, C;DeWals, P; Marlow, R; Marshall, H; Pizza, M; Rappuoli, R; Bekkat, Berkani R.
RECENT ADVANCES IN MENINGOCOCCAL B DISEASE PREVENTION: REAL WORLD EVIDENCE FROM 4CMENB VACCINATION
Swiss Medical Weekly. 2021. Junio 10;(151), 6S-6S,249
A – Factor Impacto JCR: 2.193- Q3- General & Internal Medicine

• Martinón-Torres F, Banzhoff A, Azzari C, De Wals P, Marlow R, Marshall H, Pizza M, Rappuoli R, Berkani RB
RECENT ADVANCES IN MENINGOCOCCAL B DISEASE PREVENTION: REAL-WORLD EVIDENCE FROM 4CMENB VACCINATION
J Infect. 2021Jul;83(1):17-26. Epub 2021 Apr 30
A – Factor Impacto JCR: 6.072- Q1- Medicine

• Hoggart C, Shimizu C, Galassini R, Wright VJ, Shailes H, Bellos E, Herberg JA, Pollard AJ, O’Connor D, Choi SW, Seaby EG, Menikou S, Hibberd M, Sallah N, Burgner D, Brogan P, Patel H, Kim J, Tremoulet AH, Salo E, van Stijn D, Kuijpers T, Burns JC, Levin M; International Kawasaki DiseaseGeneticsConsortium; UK Kawasaki DiseaseGeneticsConsortium; EUCLIDS Consortium (Martinón Torres, Federico)
IDENTIFICATION OF NOVEL LOCUS ASSOCIATED WITH CORONARY ARTERY ANEURYSMS AND VALIDATION OF LOCI FOR SUSCEPTIBILITY TO KAWASAKI DISEASE
Eur J Hum Genet. 2021. Dec;29(12): 1734-1744. Epub 2021 Mar 26
A – Factor Impacto JCR: 4.246- Q2- Genetics&Heredity

• Gómez-Carballa A, Barral-Arca R, Cebey-López M, Bello X, Pardo-Seco J, Martinón-Torres F, Salas A
IDENTIFICATION OF A MINIMAL 3-TRANSCRIPT SIGNATURE TO DIFFERENTIATE VIRAL FROM BACTERIAL INFECTION FROM BEST GENOME-WIDE HOST RNA BIOMARKERS: A MULTI-COHORT ANALYSIS
Int J Mol Sci. 2021. Mar 19; 22(6):3148
A – Factor Impacto JCR: 5.924- Q1 – Biochemistry& Molecular Biology

• Rivero-Calle I, Gómez-Rial J, Bont L, Gessner BD, Kohn M, Dagan R, Payne DC, Bruni L, Pollard AJ, García-Sastre A, Faustman DL, Osterhaus A, Butler R, Giménez Sánchez F, Álvarez F, Kaforou M, Bello X, Martinón-Torres F
TIPICO X: REPORT OF THE 10TH INTERACTIVE INFECTIOUS DISEASE WORKSHOP ON INFECTIOUS DISEASES AND VACCINES
Hum VaccinImmunother. 2021. Mar 4;17(3):759-772
A – Factor Impacto JCR: 3.452- Q2 – Biotechnology & Applied microbiology

• Ortiz de Lejarazu R, Martinón Torres F, Gil de Miguel A, Díez Domingo J,RedondoMarguello E
HIGH-DOSE TRIVALENT INFLUENZA VACCINE: SAFETY AND IMMUNOGENICITY
[Vacuna antigripal trivalente de alta dosis: seguridad e inmunogenicidad]
Rev EspQuimioter. 2021. Feb;34(1):1-11
A – Factor Impacto JCR: 1.553- Q4- Microbiology

• Broset E, Pardo-Seco J, Kanno AI, Aguilo N, Dacosta AI, Rivero-Calle I, Gonzalo-Asensio J, Locht C, Leite LCC, Martin C, Martinón-Torres F
BCG VACCINATION IMPROVES DTAP IMMUNE RESPONSES IN MICE AND IS ASSOCIATED WITH LOWER PERTUSSIS INCIDENCE IN ECOLOGICAL EPIDEMIOLOGICAL STUDIES
EBioMedicine. 2021. Mar 9;65:103254
A – Factor de impacto JCR: 8.143- Q1- Medicine, Research& Experimental

• Cunningham S, Piedra PA, Martinon-Torres F, Szymanski H, Brackeva B, Dombrecht E, Detalle L, Fleurinck C; RESPIRE studygroup
NEBULISED ALX-0171 FOR RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT INFECTION IN HOSPITALISED CHILDREN: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B TRIAL
Lancet Respir Med. 2021. 21 Jan;9(1):21-32
A – Factor de Impacto JCR: 30.7- Q1- D1- Critical Care Medicine

• Martinón-Torres F, Halperin SA, Nolan T, Tapiéro B, Perrett KP, de la Cueva IS, García-Sicilia J, Stranak Z, Vanderkooi OG, Kosina P, Rumlarova S, Virta M, Arribas JMM, Miranda-Valdivieso M, Novas BA, Bozensky J, Ortega MJC, Amador JTR, Baca M, Palomino EE, Zuccotti GV, Janota J, Marchisio PG, Kostanyan L, Meyer N, Ceregido MA, Cheuvart B, Kuriyakose SO, Mesaros N
IMPACT OF MATERNAL DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINATION ON PERTUSSIS BOOSTER IMMUNE RESPONSES IN TODDLERS: FOLLOW-UP OF A RANDOMIZED TRIAL
Vaccine. 2021. Mar 12;39(11):1598-1608
A – Factor de Impacto JCR: 3.641- Q3- Medicine, Research& Experimental

• GeneticsofExfoliationSyndromePartnership, Li Z, Wang Z, Lee MC, Zenkel M, Peh E, Ozaki M, Topouzis F, Nakano S, Chan A, Chen S, Williams SEI, Orr A, Nakano M, Kobakhidze N, Zarnowski T, Popa-Cherecheanu A, Mizoguchi T, Manabe SI, Hayashi K, Kazama S, Inoue K, Mori Y, Miyata K, Sugiyama K, Higashide T, Chihara E, Ideta R, Ishiko S, Yoshida A, Tokumo K, Kiuchi Y, Ohashi T, Sakurai T, Sugimoto T, Chuman H, Aihara M, Inatani M, Mori K, Ikeda Y, Ueno M, Gaston D, Rafuse P, Shuba L, Saunders J, Nicolela M, Chichua G, Tabagari S, Founti P, Sim KS, Meah WY, Soo HM, Chen XY, Chatzikyriakidou A, Keskini C, Pappas T, Anastasopoulos E, Lambropoulos A, Panagiotou ES, Mikropoulos DG, Kosior-Jarecka E, Cheong A, Li Y, Lukasik U, Nongpiur ME, Husain R, Perera SA, Álvarez L, García M, González-Iglesias H, Cueto AFV, Cueto LFV, Martinón-Torres F, Salas A, Oguz Ç, Tamcelik N, Atalay E, Batu B, Irkec M, Aktas D, Kasim B, Astakhov YS, Astakhov SY, Akopov EL, Giessl A, Mardin C, Hellerbrand C, Cooke Bailey JN, Igo RP Jr, Haines JL, Edward DP, Heegaard S, Davila S, Tan P, Kang JH, Pasquale LR, Kruse FE, Reis A, Carmichael TR, Hauser M, Ramsay M, Mossböck G, Yildirim N, Tashiro K, Konstas AGP, Coca-Prados M, Foo JN, Kinoshita S, Sotozono C, Kubota T, Dubina M, Ritch R, Wiggs JL, Pasutto F, Schlötzer-Schrehardt U, Ho YS, Aung T, Tam WL, Khor CC
ASSOCIATION OF RARE CYP39A1 VARIANTS WITH EXFOLIATION SYNDROME INVOLVING THE ANTERIOR CHAMBER OF THE EYE
JAMA. 2021. Feb 23;325(8):753-764
A – Factor de Impacto JCR: 56.274- Q1- D1- General &Internal Medicine

• Fernández-Prada M, Rivero-Calle I, Calvache-González A, Martinón-Torres F
ACUTE ONSET SUPRACLAVICULAR LYMPHADENOPATHY COINCIDING WITH INTRAMUSCULAR MRNA VACCINATION AGAINST COVID-19 MAY BE RELATED TO VACCINE INJECTION TECHNIQUE, SPAIN, JANUARY AND FEBRUARY 2021
Euro Surveill. 2021. Mar;26(10):2100193
A – Factor de Impacto JCR: 6,307- Q1- D1- InfectiousDiseases

• Hagedoorn NN, Wagenaar JHL, Nieboer D, Bath D, VonBoth U, Carrol ED, Eleftheriou I, Emonts M, Van Der Flier M, De Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon-Torres F, Nijman R, Pokorn M, Rivero Calle I, Tsolia M, Yeung S, Zavadska D, Zenz W, Vermont CL, Oostenbrink R, Moll HA, PERFORM consortium.
IMPACT OF A CLINICAL DECISION RULE ON ANTIBIOTIC PRESCRIPTION FOR CHILDREN WITH SUSPECTED LOWER RESPIRATORY TRACT INFECTIONS PRESENTING TO EUROPEAN EMERGENCY DEPARTMENTS: A SIMULATION STUDY BASED ON ROUTINE DATA
J AntimicrobChemother. 2021. Apr 13;76(5):1349-1357
A – Factor de Impacto JCR: 5.79- Q1- InfectiousDiseases

• Molina J, González-Gamarra A, Ginel L, Peláez ME, Juez JL, Artuñedo A, Aldana G, Quesada E, Cabré JJ, Gómez A, Linares M, Marín MT, Yolanda Sanchez P, Núñez L, Gonzálvez J, Mascarós E, López J, Cano A, Herrero J, Carmen Serra M, Cimas E, Pedrol M, Alfaro JV, Martinón-Torres F, Cifuentes I, Méndez C, Ocaña D, OnBehalfOfTheCappricStudyGroup
CAPPRIC STUDY-CHARACTERIZATION OF COMMUNITY-ACQUIRED PNEUMONIA IN SPANISH ADULTS MANAGED IN PRIMARY CARE SETTINGS
Microorganisms. 2021. Feb 28;9(3):508.
A – Factor de Impacto JCR: 4.128 – Q2 – Microbiology

• Gómez-Carballa A, Barral-Arca R, Cebey-López M, Currás-Tuala MJ, Pischedda S, Gómez-Rial J, Habgood-Coote D, Herberg JA, Kaforou M, Martinón-Torres F, Salas A
HOST TRANSCRIPTOMIC RESPONSE FOLLOWING ADMINISTRATION OF ROTAVIRUS VACCINE IN INFANTS’ MIMICS WILD TYPE INFECTION
Front Immunol. 2021. Jan 21;11:580219
A – Factor Impacto JCR: 7.561- Q1- Immunology

• Van derVliet D, Vesikari T, Sandner B, Martinón-Torres F, Muzsay G, Forsten A, Adelt T, Diaz Gonzalez C, Simko R, B’Chir S, Neveu D, Jordanov E, Dhingra MS
IMMUNOGENICITY AND SAFETY OF A QUADRIVALENT MENINGOCOCCAL TETANUS TOXOID-CONJUGATE VACCINE (MENACYW-TT) VERSUS A LICENSED QUADRIVALENT MENINGOCOCCAL TETANUS TOXOID-CONJUGATE VACCINE IN MENINGOCOCCAL VACCINE-NAÏVE AND MENINGOCOCCAL C CONJUGATE VACCINE-PRIMED TODDLERS: A PHASE III RANDOMIZED STUDY
Epidemiol Infect. 2021 Feb 5;149: e50.
A – Factor de impacto JCR: 2.455- Q3- InfectiousDiseases

• Serra L, Knuf M, Martinón-Torres F, Yi K, Findlow J
REVIEW OF CLINICAL STUDIES COMPARING MENINGOCOCCAL SEROGROUP C IMMUNE RESPONSES INDUCED BY MENACWY-TT AND MONOVALENT SEROGROUP C VACCINES
Hum VaccinImmunother. 2021 Jul 3;17(7):2205-2215. Epub 2021 Feb 19
A – Factor de impacto JCR: 3.452- Q2- Biotechnology&AppliedMicrobiology

• Borensztajn DM, Hagedoorn NN, Rivero Calle I, Maconochie IK, von Both U, Carrol ED, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Martinon-Torres F, Nieboer D, Nijman RG, Pokorn M, Strle F, Tsolia M, Vermont C, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union
VARIATION IN HOSPITAL ADMISSION IN FEBRILE CHILDREN EVALUATED AT THE EMERGENCY DEPARTMENT (ED) IN EUROPE: PERFORM, A MULTICENTRE PROSPECTIVE OBSERVATIONAL STUDY
PLoSOne 2021 Jan 7;16(1): e0244810.
A – Factor de impacto JCR: 3.24 – Q2- MultidisciplinarySciencies

• Pischedda S, O’Connor D, Fairfax BP, Salas A, Martinon-Torres F, Pollard AJ, Trück J.
CHANGES IN EPIGENETIC PROFILES THROUGHOUT EARLY CHILDHOOD AND THEIR RELATIONSHIP TO THE RESPONSE TO PNEUMOCOCCAL VACCINATION
Clin Epigenetics. 2021 Feb 4;13(1):29
A – Factor de impacto JCR: 6.551- Q1- Genetics&Heredity

• Pardo-Seco J, Gómez-Carballa A, Bello X, Martinón-Torres F, Salas A.
PITFALLS OF BARCODES IN THE STUDY OF WORLDWIDE SARS-COV-2 VARIATION AND PHYLODYNAMICS.
Zoological Research, 2021, Jan 18;42(1): 87-93
A – Factor de impacto JCR: 4.56- Q1- D1 – Zoology

• Antonio Salas, Sebastian Schönherr, Hans-Jürgen Bandelt, Alberto Gómez-Carballa, HansiWeissensteiner (Federico Martinón Torres)
EXTRAORDINARY CLAIMS REQUIRE EXTRAORDINARY EVIDENCE IN ASSERTED MTDNA BIPARENTAL INHERITANCE
Forensic Sci Int Genet.2020. Jul;47: 102274
A – Factor de impacto JCR: 4.882- Q1- D1- Legal Medicine

• Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F
ROTAVIRUS AND AUTOIMMUNITY
J Infect. 2020. Aug; 81(2):183-189
A – Factor de impacto JCR: 6.072- Q1- InfectiousDiseases

• Tabor, David E; Fernandes, Fiona; Langedijk, Annefleur C; Wilkins, Deidre; Lebbink, Robert Jan; Tovchigrechko, Andrey; Ruzin, Alexey; Kragten-Tabatabaie, Leyla; Jin, Hong; Esser, Mark T; Bont, Louis J; Abram, Michael E (Martinón-Torres, Federico)
GLOBAL MOLECULAR EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS FROM THE 2017-2018 INFORM-RSV STUDY
J. Clin. Microbiol. 2020. JCM.01828-20
A – Factor de impacto JCR: 5.948- Q1- Microbiology

• Esther Willems Laura Lorés‐Motta Andrea Zanichelli Chiara SuffrittiMichiel van der Flier Renate G van der Molen Jeroen D Langereis Joris van Drongelen Lambert P van den Heuvel Elena Volokhina Nicole CAJ van de Kar Jenneke Keizer‐Garritsen Michael Levin Jethro A Herberg Federico Martinon‐Torres Hans JTC Wessels Anita de Breuk Sascha FauserCarel B Hoyng Anneke I den Hollander Ronald de Groot Alain J van Gool JoleinGloerichMarien I de Jonge
QUANTITATIVE MULTIPLEX PROFILING OF THE COMPLEMENT SYSTEM TO DIAGNOSE COMPLEMENT‐MEDIATED DISEASES
Clinical & Translational Immunology, 2020 Volume 9, Issue 12
A – Factor Impacto JCR: 6.161- Q2 – Immunology

• Nienke N Hagedoorn, Dorine Borensztajn, Ruud Gerard Nijman, DaanNieboer, Jethro Adam Herberg, Anda Balode, Ulrich von Both, Enitan Carrol, IriniEleftheriou, Marieke Emonts, Michiel van der Flier, Ronald de Groot, Benno Kohlmaier, Emma Lim, Ian Maconochie, Federico Martinón-Torres, Marko Pokorn, Franc Strle, Maria Tsolia, Dace Zavadska, Werner Zenz, Michael Levin, Clementien Vermont, Henriette A Moll
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INVASIVE BACTERIAL INFECTIONS IN FEBRILE CHILDREN AT EUROPEAN EMERGENCY DEPARTMENTS: MOFICHE, A PROSPECTIVE OBSERVATIONAL STUDY
Arch Dis Child. 2020 Nov 18; archdischild-2020-319794
A – Factor Impacto JCR: 3.801- Q1- Pediatrics

• R Ortiz de Lejarazu, F Martinón Torres, A Gil de Miguel, J Díez Domingo, E Redondo Marguello
HIGH-DOSE TRIVALENT INFLUENZA VACCINE: SAFETY AND IMMUNOGENICITY
[Vacuna antigripal trivalente de alta dosis: seguridad e inmunogenicidad]
Rev. EspQuimioter. 2020 Nov 19:legarazu19nov2020
A – Factor Impacto JCR: 1,153- Q4- Microbiology

• Susanna Esposito, Marcus Herbert Jones, WojciechFeleszko, José A. Ortega Martell, OanaFalup-Pecurariu, Natalia Geppe , Federico Martinón-Torres, Kun-Ling Shen, Michael Roth and Nicola Principi
PREVENTION OF NEW RESPIRATORY EPISODES IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS: AN EXPERT CONSENSUS STATEMENT FROM THE WORLD ASSOCIATION OF INFECTIOUS DISEASES AND IMMUNOLOGICAL DISORDERS (WAIDID)
Microorganisms 2020 Nov 17, 8(11): E1810
A – Factor de Impacto JCR4.128- Q2 – Microbiology

• F Martinón-Torres, SA Halperin, T Nolan, B tapiero, KP Perrett, IS de la Cueva, J García-Sicilia, Z Stranak, Vanderkooifloor, P Kosina, M Virta, JM Merino Arribas, M Miranda-Valdivieso, B Arias Novas, J Bozensky, MJ Cilleruelo Ortega, JT Ramos Amador, M Baca, Palomino E Escribano, GV Zuccotti, J Janota, PG Marchisio, L Kostanyan, N Meyer, MA Ceregido, B Cheuvart, SO Kuriyakose, N Mesaros;
IMMUNANTWORT AUF DIE DTPA-HBV-IPV/HIB-AUFFRISCHIMPFUNG BEI KLEINKINDERN VON MÜTTERN, DIE WÄHREND DER SCHWANGERSCHAFT MIT TDAP-IMPFSTOFF GEIMPFT WORDEN WAREN: FOLGESTUDIE EINER RANDOMISIERTEN, PLACEBOKONTROLLIERTEN STUDIE
GeburtshilfeFrauenheilkd 2020; 80(10): e84-e85
A – Factor de Impacto JCR: 2.915 – Q2 – Obstetrics & Gynecology

• Gu-Lung Lin, Tanya Golubchik, Simon Drysdale, Daniel O’Connor, Kimberley Jefferies, Anthony Brown, Mariateresa de Cesare, David Bonsall, M. Azim Ansari, Jeroen Aerssens, Louis Bont, Peter Openshaw, Federico Martinón-Torres, Rory Bowden, and Andrew J. Pollard; the RESCEU Investigators
SIMULTANEOUS VIRAL WHOLE-GENOME SEQUENCING AND DIFFERENTIAL EXPRESSION PROFILING IN RESPIRATORY SYNCYTIAL VIRUS INFECTION OF INFANTS
J Infect Dis. 2020 Oct 7;222(Supplement_7):S666-S671
A – Factor Impacto JCR: 5.226 – Q1- Infectious Diseases

• Marta Vazquez-Ortiz, Laura Argiz, Adrianna Machinena, Luis Echeverria, Cristina Blasco, Ana Prieto, Sonsoles Infante, Leticia Vila, Emilio Garcia, PurificacionGonzalez-Delgado, Sonia Vazquez-Cortes, Simona Barni, Federico Martinon-Torres
REPLY TO ‘‘DIAGNOSTIC CRITERIA SETS SENSITIVITY’’
J Allergy Clin ImmunolPract. 2020 Sep;8(8):2840-2841.e1.
A- Factor de impacto JCR: 8.861 – Q1- AllergyImmunology

• JoseGomez Rial, MariaJose Curras Tuala, Irene Rivero Calle, Alberto GomezCarballa, Miriam CebeyLopez, Carmen RodriguezTenreiro, Ana Dacosta Urbieta, Carmen Rivero Velasco, Nuria RodriguezNunez, RocioTrastoy Pena, Javier RodriguezGarcia, Antonio Salas, Federico Martinon Torres
INCREASED SERUM LEVELS OF SCD14 AND SCD163 INDICATE A PREPONDERANT ROLE FOR MONOCYTES IN COVID-19 IMMUNOPATHOLOGY
Front Immunol. 2020 Sep 23;11: 560381. doi: 10.3389/fimmu.2020.560381. eCollection 2020
A – Factor de impacto JCR: 7.561- Q1- Inmunology

• Ana Dacosta-Urbieta, Irene Rivero-Calle, Jacobo Pardo-Seco, Lorenzo Redondo-Collazo, Antonio Salas, Jose Gómez-Rial and Federico Martinón-Torres
SEROPREVALENCE OF SARS-COV-2 AMONG PEDIATRIC HEALTHCARE WORKERS IN SPAIN
Front. Pediatr. 2020 Sep 11; 8:547
A- Factor de impacto JCR: 3.418- Q1- Pediatrics

• Emma Jones, Holger Hummerich, Emmanuelle Viré, James Uphill, AthanasiosDimitriadis, Helen Speedy, Tracy Campbell, Penny Norsworthy, Liam Quinn, Jerome Whitfield, Jacqueline Linehan, Zane Jaunmuktane, SebastianBrandner, ParmjitJat, AkinNihat, TzeHowMok, Parvin Ahmed, Steven Collins, ChristianeStehmann, Shannon Sarros, Gabor G Kovacs, Michael D Geschwind, AiliGolubjatnikov, Karl Frontzek, Herbert Budka, Adriano Aguzzi, HataKaramujić-Čomić, Sven J van der Lee, Carla A Ibrahim-Verbaas, Cornelia M Van Duijn, Beata Sikorska, EwaGolanska, PawelLiberski, Miguel Calero, Olga Calero, Pascual Sanchez-Juan, Antonio Salas, Federico Martinón-Torres, Elodie Bouaziz-Amar, Stephane Haik, Jean-Louis Laplanche, Jean-Phillipe Brandel, Phillipe Amouyel, Jean-Charles Lambert, Piero Parchi, Anna Bartoletti-Stella, Sabina Capellari, Anna Poleggi, Anna Ladogana, MaurizioPocchiari, Serena Aneli, Giuseppe Matullo, Richard Knight, Saima Zafar, Inga Zerr, Stephanie Booth, Michael B Coulthart, Gerard H Jansen, Katie Glisic, Janis Blevins, Pierluigi Gambetti, JiriSafar, Brian Appleby, John Collinge, Simon Mead
IDENTIFICATION OF NOVEL RISK LOCI AND CAUSAL INSIGHTS FOR SPORADIC CREUTZFELDT-JAKOB DISEASE: A GENOME-WIDE ASSOCIATION STUDY
Lancet Neurol. 2020 Oct;19(10):840-848
A – Factor de impacto JCR: 44.182- Q1- D1 – Neurosciences & Neurology

• Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F.
ROLE OF MONOCYTES/MACROPHAGES IN COVID-19 PATHOGENESIS: IMPLICATIONS FOR THERAPY.
Infect Drug Resist. 2020 Jul 22;13:2485-2493
A – Factor de impacto JCR: 4.003- Q2- Infectious Diseases

• Kimberley Jefferies,Simon B Drysdale,HannahRobinson,Elizabeth Ann Clutterbuck,LukeBlackwell,JosephMcGinley,Gu-Lung Lin,UshmaGalal,HarishNair,JeroenAerssens,DenizÖner,AnnefleurLangedijk,LouisBont,Joanne G Wildenbeest,FedericoMartinon-Torres, Carmen Rodríguez-Tenreiro Sánchez, Simon Nadel, Peter Openshaw, Ryan Thwaites, Myra Widjojoatmodjo, Linong Zhang, Thi Lien-Anh Nguyen, Carlo Giaquinto, Giuseppe Giordano, Eugenio Baraldi, Andrew J Pollard, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
PRESUMED RISK FACTORS AND BIOMARKERS FOR SEVERE RESPIRATORY SYNCYTIAL VIRUS DISEASE AND RELATED SEQUELAE: PROTOCOL FOR AN OBSERVATIONAL MULTICENTER, CASE-CONTROL STUDY FROM THE RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU)
J Infect Dis, jiaa239. 2020 Oct 7;222(Suppl 7):S658-S665
A – Factor Impacto JCR: 5,226 – Q1- Infectious Diseases

• Öner D, Drysdale SB, McPherson C, Lin GL, Janet S, Broad J, Pollard AJ, Aerssens J; RESCEU Investigators (F Martinón-Torres)
BIOMARKERS FOR DISEASE SEVERITY IN CHILDREN INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS: A SYSTEMATIC LITERATURE REVIEW.
J Infect Dis. 2020 Oct 7;222(Supplement_7):S648-S657
A – Factor Impacto JCR: 5,226 – Q1- Infectious Diseases

• Judith Zandstra, Annemarie van de Geer, Michael W T Tanck, Diana van Stijn-Bringas, Dimitriades, Cathelijn E M Aarts, Sanne M Dietz, Robin van Bruggen, Nina A Schweintzger, Werner Zenz, Marieke Emonts, Dace Zavadska, Marko Pokorn, EffuaUsuf, Henriette A Moll, Luregn J Schlapbach, Enitan D Carrol, Stephane Paulus, Maria Tsolia, Colin Fink, Shunmay Yeung, Chisato Shimizu, Adriana Tremoulet, Rachel Galassini, Victoria J Wright, Federico Martinón-Torres, Jethro Herberg, Jane Burns, Michael Levin, Taco W Kuijpers, EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
BIOMARKERS FOR THE DISCRIMINATION OF ACUTE KAWASAKI DISEASE FROM INFECTIONS IN CHILDHOOD
Front Pediatr 2020 Jul 22;8:355
A- Factor de impacto JCR: 3.418- Q1 – Pediatrics

• Joanne G Wildenbeest, Roy P Zuurbier, KoosKorten, Marlies A van Houten, Marie N Billard, Nicole Derksen-Lazet, Matthew D Snape, Simon B Drysdale, Hannah Robinson, Andrew J Pollard, Terho Heikkinen, Steve Cunningham, Amanda Leach, Federico Martinón-Torres, Carmen Rodríguez-Tenreiro Sánchez, Alberto Gómez-Carballa, Louis J Bont, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU) BIRTH COHORT STUDY: DEFINING THE BURDEN OF INFANT RESPIRATORY SYNCYTIAL VIRUS DISEASE IN EUROPE
J InfectDis. 2020. Oct 7;222(Suppl 7):S606-S612
A – Factor Impacto JCR: 5,226 – Q1- Infectious Diseases

• M. Pamela Griffin, Yuan Yuan, Therese Takas, Joseph B. Domachowske, Shabir A. Madhi, Paolo Manzoni, Eric A.F. Simões, Mark T. Esser, Anis A. Khan, FilipDubovsky, TonyaVillafana and John P. DeVincenzofortheNirsevimabStudyGroup*(Federico Martinón Torres)
SINGLE-DOSE NIRSEVIMAB FOR PREVENTION OF RSV IN PRETERM INFANTS
N Engl J Med 2020;383:415-25.
A- Factor de impacto JCR: 91.253- Q1- D1- General &Internal Medicine

• S.A. Madhi, F.P. Polack, P.A. Piedra, F.M. Munoz, A.A. Trenholme, E.A.F. Simões, G.K. Swamy, S. Agrawal, K. Ahmed, A. August, A.H. Baqui, A. Calvert, J. Chen, I. Cho, M.F. Cotton, C.L. Cutland, J.A. Englund, A. Fix, B. Gonik, L. Hammitt, P.T. Heath, J.N. de Jesus, C.E. Jones, A. Khalil, D.W. Kimberlin, R. Libster, C.J. Llapur, M. Lucero, G. Pérez Marc, H.S. Marshall, M.S. Masenya,F. Martinón‐Torres, J.K. Meece, T.M. Nolan, A. Osman, K.P. Perrett, J.S. Plested, P.C. Richmond, M.D. Snape, J.H. Shakib, V. Shinde, T. Stoney, D.N. Thomas, A.T. Tita, M.W. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H.J. Zar, G.M. Glenn, and L.F. Fries, forthe Prepare StudyGroup*
RESPIRATORY SYNCYTIAL VIRUS VACCINATION DURING PREGNANCY AND EFFECTS IN INFANTS
N Engl J Med. 2020. Jul 30;383(5):426-439
A- Factor de impacto JCR: 91.253- Q1- D1- General &Internal Medicine

• J.Gómez-Rial, F.Martinón-Torres (correspondingauthor- letter)
A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION
Clin Immunol. 2020 Jul; 216: 108442
A- Factor de impacto JCR: 3,969- Q3 – Immunology

• Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; MyrsiniKaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
JAMA. 2020 Jul 21;324(3):259-269
A- Factor de impacto JCR: 56.274- Q1- D1- Medicine General &Internal

• Gómez-Carballa A, Bello X, Pardo-Seco J, Del Molino MLP, Martinón-Torres F, Salas A.
PHYLOGEOGRAPHY OF SARS-COV-2 PANDEMIC IN SPAIN: A STORY OF MULTIPLE INTRODUCTIONS, MICRO-GEOGRAPHIC STRATIFICATION, FOUNDER EFFECTS, AND SUPER-SPREADERS.
Zoologicalresearch. 2020;41(6):605
A – Factor de impacto JCR: 4.56- Q1- D1 – Zoology

• Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Genome Res. 2020 Oct;30(10):1434-1448
A – Factor de impacto JCR: 9.043- Q1- D1- Biotechnology&AppliedMicrobiology

• Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Int J Mol Sci. 2020.Apr 21(8) 21082748
A – Factor Impacto JCR: 5.924- Q1 – Biochemistry& Molecular Biology

• Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators (F. Martinón-Torres)
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Infect Dis. 2020 Oct 7;222(Supplement_7):S680-S687
A – Factor Impacto JCR: 5.226- Q1- Infectious Diseases

• Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators (F. Martinón Torres)
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
J Infect Dis. 2020 Oct 7;222(Supplement_7):S584-S591
A – Factor Impacto JCR: 5.226- Q1- Infectious Diseases

• Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
J Infect Dis. 2020 Oct 7;222(Supplement_7): S640-S647
A – Factor Impacto JCR: 5.226- Q1- Infectious Diseases

• Martinón-Torres F, Serra L, Safadi MAP.
PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.
Expert Rev Vaccines. 2020 Apr;19(4):313-325
A – Factor de impacto JCR: 5.217- Q2- Immunology

• Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A
PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.
Hum VaccinImmunother. 2020 Nov 1;16(11):2873-2884.
A – Factor Impacto JCR: 3.452 – Q2- Biotechnology & applied microbiology

• Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, EvangelosBellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, GiancardloNatalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study
WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS – A PROSPECTIVE POPULATION-BASED COHORT STUDY
ClinicalInfectiousDiseases, ciaa290. 2020 Dec 17;71(10):e614-e623
A – Factor de impacto JCR:9.079- Q1- D1- InfectiousDiseases

• Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, Xabier Bello, Federico Martinón-Torres, and Antonio Salas
A META-ANALYSIS OF MULTIPLE WHOLE BLOOD GENE EXPRESSION DATA UNVEILS A DIAGNOSTIC HOST-RESPONSE TRANSCRIPT SIGNATURE FOR RESPIRATORY SYNCYTIAL VIRUS
Int. J. Mol. Sci. 2020. Mar 6;21(5):1831
A – Factor de impacto JCR:5.924- Q1 – Biochemistry& Molecular Biology

• Federico Martinón-Torres, Sarah Rusch, DymphyHuntjens, Bart Remmerie, Johan Vingerhoets, Katie McFadyen, Fernando Ferrero, Eugenio Baraldi, Pablo Rojo, Cristina Epalza, Marita Stevens
PHARMACOKINETICS, SAFETY AND ANTIVIRAL EFFECTS OF MULTIPLE DOSES OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR, JNJ-53718678, IN INFANTS HOSPITALIZED WITH RSV INFECTION: A RANDOMIZED PHASE 1B STUDY
ClinicalInfectiousDiseases, ciaa283. 2020 Dec 17;71(10):e594-e603
A – Factor de impacto JCR:9.079- Q1- D1- InfectiousDiseases

• GhassanDbaibo, ArshadAmanullah, CarineClaeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, JyotiSoni, Emad Yanni, KhalequZaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, AshishBavdekar, Alfonso Carmona, Luis Cousin, JasurDanier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, JoseGarcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, MustafaHacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, RomanPrymula, ThanyaweePuthanakit, Renata Ruzkova, IwonaSadowska-Krawczenko Henryk Szymanski, AngelsUlied, Wayne Woo, Anne Schuind and Bruce L. Innisforthe Flu4VEC StudyGroup
QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL
Pediatr Infect Dis J. 2020 Jan;39(1): e1-e10
A – Factor de impacto JCR:2.129- Q3- Pediatrics

• Chaw PS, Hua L, Cunningham S, Campbell H, Mikolajczyk R, Nair H; RESCEU Investigators (Nair H, Campbell H, Shi T, Zhang S, Li Y, Hua L, Openshaw P, Wedzicha J, Falsey A, Miller M, Bont L, Pollard A, Molero E, Martinon-Torres F, Heikkinen T, Meijer A, Fischer TK, van den Berge M, Giaquinto C, Mikolajczyk R, Chaw PS, Gallichan S, Kieffer A, Demont C, Hackett J, Cai B, Knirsch C, Leach A, Stoszek S, Cheret A, Gavart S, Aerssens J, Fuentes R, Rosen B)
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTIONS IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: SYSTEMATIC REVIEW AND META-ANALYSIS.
J Infect Dis. 2020 Oct 7;222(Supplement_7):S680-S687
A – Factor Impacto JCR: 5,226- Q1- Infectious Diseases

• Nunez Cuadros, Esmeralda; Calvo Rey, Cristina; Saavedra-Lozano, Jesus and Red RIOPED (Federico Martinón and Irene Rivero)
EVALUATION OF THE IMPACT OF THE SPANISH CONSENSUS DOCUMENT ON THE APPROACH TO OSTEOARTICULAR INFECTIONS IN SPAIN THROUGH THE PAEDIATRICS OSTEOARTICULAR INFECTIONS NETWORK (RIOPED).
AnPediatr (Barc). 2020 Nov;93(5):289-296
A – Factor de impacto JCR: 1.500- Q4 – Pediatrics

• Marta Vazquez-Ortiz, Laura Argiz, Adrianna Machinena, Luis Echeverria, Cristina Blasco, Ana Prieto, Sonsoles Infante, Leticia Vila, Emilio Garcia, Purificación Gonzalez-Delgado, SoniaVazquez-Cortes, Simona Barni, FredericoMartinon-Torres, BIO-FPIES studynetwork
DIAGNOSTIC CRITERIA FOR ACUTE FPIES: WHAT ARE WE MISSING?
J Allergy Clin Immunol Pract. 2020 May;8(5):1717-1720.e2.
A – Factor Impacto JCR: 8.861 – Q1- Allergy

• Kirsten P. Perrett, Scott A. Halperin, Terry Nolan, Cristina Martínez Pancorbo, Bruce Tapiero, Federico Martinón-Torres, ZbynekStranak, MiiaVirta, Otto G. Vanderkooi, Pavel Kosina, Maria Begoña Encinas Pardilla, Ignacio Cristobal García, Gian VincenzoZuccotti, LusineKostanyanm, Nadia Meyer, MariaAngelesCeregido, Brigitte Cheuvart, Sherine O. Kuriyakose, Manuel Marcos Fernández, Miguel Ángel Rodríguez Zambrano, Adrián Martín García, Juan Eloy Asenjo de la Fuente, Maria Dolores Camacho Marín, María de la Calle Fernández-Miranda, Yolanda Romero Espinar, Paola Giovanna Marchisio, Paolo Manzoni, Narcisa Mesaros
IMMUNOGENICITY, TRANSPLACENTAL TRANSFER OF PERTUSSIS ANTIBODIES AND SAFETY FOLLOWING PERTUSSIS IMMUNIZATION DURING PREGNANCY: EVIDENCE FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Vaccine Feb 2020, 38 (8) 2095-2104
A – Factor Impacto JCR: 3.641- Q3- Medicine Research & Experimental

• Kirsten P. Perrett, Scott A. Halperin, Terry Nolan, Alfonso Carmona Martínez, Federico Martinón-Torres, Jose García-Sicilia, MiiaVirta , Otto G. Vanderkooi, Gian VincenzoZuccotti, Paolo Manzoni, LusineKostanyan, Nadia Meyer, MariaAngelesCeregido, Brigitte Cheuvart , Sherine O. Kuriyakose l, ZbynekStranak, Jose M. Merino Arribas, María José Cilleruelo Ortega, Mariano Miranda-Valdivieso, Begoña Arias Novas, Jose Tomas Ramos Amador, FelixOmeñaca, Manuel Baca, Paola Giovanna Marchisio, Narcisa Mesaros
IMPACT OF TETANUS-DIPHTHERIA-ACELLULAR PERTUSSIS IMMUNIZATION DURING PREGNANCY ON SUBSEQUENT INFANT IMMUNIZATION SERORESPONSES: FOLLOW-UP FROM A LARGE RANDOMIZED PLACEBO-CONTROLLED TRIAL
Vaccine, feb 2020, 38 (8) 2105-2114
A – Factor Impacto JCR: 3.641- Q3- Medicine Research & Experimental

• Laura Argiz, Sonsoles Infante, Adrianna Machinena, Mariona Pascal, Luis Echeverria, Simona Barni, Teresa Garriga-Baraut, StefaniaArasi, Jose Domingo Moure, Alberto Gomez-Carballa, Federico Martinon-Torres, Robert J Boyle, Marta Vazquez-Ortiz, BIO-FPIES studynetwork
REACTIONS ON RE-EXPOSURE FOLLOWING NEGATIVE AND INCONCLUSIVE FOLLOW-UP FOOD CHALLENGES IN CHILDREN WITH ACUTE FPIES
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3228-3231.e3
A – Factor Impacto JCR: 8.861 – Q1- Allergy

• Ruggieri L, Bonifazi D, Landi A, Bonifazi F, Bartoloni F, Costello M, Felisi MG, Gasthuys E, Godo A, Martinon Torres F, Nadal D, Nuytinck L, Rocchi F, Turner M, Ceci A
SURVEY BY TEDDY EUROPEAN NETWORK OF EXCELLENCE FOR PAEDIATRIC CLINICAL RESEARCH DEMONSTRATES POTENTIAL FOR EUROPE-WIDE TRIALS
Acta Paediatr. 2020. Mar;109(3):607-612. Epub 2019 Oct 13
A – Factor Impacto JCR: 2.299- Q2 – Pediatrics

• Federico Martinón-Torresy Antoni Trillac
MENINGOCOCCAL DISEASE: CAN WE PREDICT THE UNPREDICTABLE?
Med Clin (Barc). 2020 Jan 10;154(1):20-22
A – Factor impacto JCR: 1.725- Q3- Medicine General & Internal

• I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. MartinónSanchez and F. Martinón-Torres
ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN
Hum VaccinImmunother 2020 Jun 2;16(6):1446-1453
A – Factor Impacto JCR: 3.452- Q2- Biotechnology & applied microbiology

• Shi T, Ooi Y, Zaw EM, Utjesanovic N, Campbell H, Cunningham S, Bont L, Nair H, RESCEU Investigators. COLLABORATORS (Nair H, Campbell H, Shi T, Zhang S, Li Y, Openshaw P, Wedzicha J, Falsey A, Miller M, Beutels P, Bont L, Pollard A, Molero E, Martinon-Torres F, Heikkinen T, Meijer A, Fischer TK, Berge MVD, Giaquinto C, Mikolajczyk R, Hackett J, Cai B, Knirsch C, Leach A, Stoszek SK, Gallichan S, Kieffer A, Demont C, Cheret A, Gavart S, Aerssens J, Wyffels V, Cleenewerck M, Fuentes R, Rosen B.)
ASSOCIATION BETWEEN RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION IN EARLY LIFE AND RECURRENT WHEEZE AND ASTHMA IN LATER CHILDHOOD.
The Journal of Infectious Diseases, 222, 7, 1 November 2020, 628–S633
A – Factor Impacto JCR: 5,226- Q1- Infectious Diseases

• Xinzhu Wang, RuudNijman, Stephane Camuzeaux, Caroline Sands, Heather Jackson, MyrsiniKaforou, MariekeEmonts, Jethro A. Herberg, Ian Maconochie, Enitan D. Carrol, Stephane C. Paulus, Werner Zenz, Michiel Van derFlier, Ronald de Groot, Federico Martinon-Torres, Luregn J. Schlapbach, Andrew J. Pollard, Colin Fink, Taco T. Kuijpers, Suzanne Anderson, Matthew R. Lewis, Michael Levin, Myra McClure & EUCLIDS consortium
PLASMA LIPID PROFILES DISCRIMINATE BACTERIAL FROM VIRAL INFECTION IN FEBRILE CHILDREN
Scientific Reports (2019) 9:17714
A – Factor Impacto JCR: 3,998 – Q1- Multidisciplinary

• F Secka, J A Herberg, I Sarr, S Darboe, G Sey, M Saidykhan, M Wathuo, M Kaforou, M Antonio, A Roca, S M A Zaman, M Cebey-López, N P Boeddha, S Paulus, D S Kohlfürst, M Emonts, W Zenz, E D Carrol, R de Groot, L Schlapbach, F Martinon-Torres, K Bojang, M Levin, M van der Flier, S T Anderson on behalf of the EUCLIDS Consortium
BACTEREMIA IN CHILDHOOD LIFE-THREATENING INFECTIONS IN URBAN GAMBIA: EUCLIDS IN WEST AFRICA
Open Forum Infectious Diseases, 2019 Sept, 6 (9) UNSP ofz332
A – Factor Impacto JCR: 3,656 – Q2- Immunology

• Pardo-Seco, J; Gomez-Carballa, A; Bello, X ; Martinon-Torres, F; Salas, A
BIOGEOGRAPHICAL INFORMATIVENESS OF Y-STR HAPLOTYPES
Science Bulletin 2019 Oct 64, (19), 1381-1384
A – Factor Impacto JCR: 9,511 – Q1- D1 Multidisciplinary

• Francisco Alvarez, Filipe Froes, Amos García Rojas, David Moreno-Perez& Federico Martinon-Torres
THE CHALLENGES OF INFLUENZA FOR PUBLIC HEALTH
Future Microbiol. 2019 Nov;14:1429-1436
A – Factor de impacto JCR: 2,907 Q3 Microbiology

• Rivero Calle, I; Raguindin PF; Gómez Rial, J; Rodríguez-Tenreiro, C; Martinón-Torres, F.
MENINGOCOCCAL GROUP B VACCINE FOR THE PREVENTION OF INVASIVE MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUP B
Infection and Drug Resistance 2019:12 3169–3188
A – Factor de impacto JCR: 2,984 – Q2 – Infectious Diseases

• Alberto Gómez-Carballa, Miriam Cebey-López, Jacobo Pardo-Seco, Ruth Barral-Arca, Irene Rivero-Calle, Sara Pischedda, María José Currás-Tuala1, José Gómez-Rial, Francisco Barros, Federico Martinón-Torres & Antonio Salas
A QPCR EXPRESSION ASSAY OF IFI44L GENE DIFFERENTIATES VIRAL FROM BACTERIAL INFECTIONS IN FEBRILECHILDREN
Scientific Reports 9, 11780 (2019). 13 Agos. s41598-019-48162-9
A – Factor Impacto JCR: 3,998 – Q1 – Multidisciplinary

• Yingfen Hsia, Brian R Lee, Ann Versporten, Yonghong Yang, Julia Bielicki, Charlotte Jackson, Jason Newland, Herman Goossens, Nicola Magrini, Mike Sharland on behalf of the GARPEC and Global-PPS networks* (Federico Martinon-Torres)
USE OF THE WHO ACCESS, WATCH, AND RESERVE CLASSIFICATION TO DEFINE PATTERNS OF HOSPITAL ANTIBIOTIC USE (AWARE): AN ANALYSIS OF PAEDIATRIC SURVEY DATA FROM 56 COUNTRIES
Lancet Glob Health 2019; 7: e861–71
A – Factor Impacto JCR: 21,597 – D1

• Federico Martinón-Torres, Terry Nolan, Daniela Toneatto& Angelika Banzhoff
PERSISTENCE OF THE IMMUNE RESPONSE AFTER 4CMENB VACCINATION, AND THE RESPONSE TO AN ADDITIONAL BOOSTER DOSE IN INFANTS, CHILDREN, ADOLESCENTS AND YOUNG ADULTS
Hum VaccinImmunother. 2019. 15 (12): 2940–2951
A – Factor Impacto JCR: 2,619– Q2- biotechnology & applied microbiology

• Irene Rivero, Peter Francis Raguindin, Robb Buttler and Federico Martinon-Torres
FALSE VACCINE CONTRAINDICATIONS AMONG HEALTHCARE PROVIDERS IN EUROPE: A SHORT SURVEY AMONG MEMBERS OF THE EUROPEAN SOCIETY OF PEDIATRIC INFECTIOUS DISEASES
Pediatr Infect Dis J. 2019 Sep;38(9):974-976
A – Factor de impacto JCR:2,126– Q2 – Pediatrics

• Willems E, Alkema W, Keizer-Garritsen J, Suppers A, van derFlier M, Philipsen RHLA, van den Heuvel LP, Volokhina E, van der Molen RG, Herberg JA, Levin M,Wright VJ, Ahout IML, Ferwerda G, Emonts M, Boeddha NP, Rivero-Calle I, Torres FM, Wessels HJCT, de Groot R, van Gool AJ, Gloerich J, de Jonge MI.
BIOSYNTHETIC HOMEOSTASIS AND RESILIENCE OF THE COMPLEMENT SYSTEM IN HEALTH AND INFECTIOUS DISEASE.
EBioMedicine. 2019 Jul;45:303-313.
A – Factor de impacto JCR: 5,736 Q1- medicine, research& experimental

• Arias Fernández L, Pardo Seco J, Cebey-López M, Gil Prieto R, Rivero-Calle I, Martinon-Torres F, Gil de Miguel Á; NEUMOEXPERTOS group, Martinón-Torres F, Vargas D, Mascarós E, Redondo E, Díaz-Maroto JL, Linares-Rufo M, Gil A, Molina J, Ocaña D, Rivero-Calle I.
DIFFERENCES BETWEEN DIABETIC AND NON-DIABETIC PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN PRIMARY CARE IN SPAIN.
BMC Infect Dis. 2019 Nov 15;19(1):973.
A – Factor de impacto JCR: 2,688 – Q3 – Infectious Diseases

• Obando-Pacheco P, Rivero-Calle I, Raguindin PF, Martinón-Torres F.
DTAP5-HBV-IPV-HIB PEDIATRIC HEXAVALENT COMBINATION VACCINE FOR USE IN CHILDREN FROM 6 WEEKS THROUGH TO 4 YEARS OF AGE.
Expert Rev Vaccines. 2019 Nov;18(11):1115-1126.
A – Factor de impacto JCR: 4,362 Q2 Immunology

• JasurDanier, Luis Rivera, Carine Claeys, Ghassan Dbaibo, Varsha K. Jain, Pope Kosalaraksa, Wayne Woo, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Arshad Amanullah, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Adolfo Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Allen Izu, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, ThanyaweePuthanakit,RenataRuzkova, Iwona SadowskaKrawczenko, Jyoti Soni, Henryk Szymanski, Angels Ulied, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group
CLINICAL PRESENTATION OF INFLUENZA IN CHILDREN 6 TO 35 MONTHS OF AGE: FINDINGS FROM A RANDOMIZED CLINICAL TRIAL OF INACTIVATED QUADRIVALENT INFLUENZA VACCINE
Pediatr Infect Dis J. 2019 Aug;38(8):866-872
A – Factor de impacto JCR:2,126– Q2 – Pediatrics

• Barral-Arca, R; Pardo-Seco, J; Bello, X; Martinon-Torres, F; Salas, A
ANCESTRY PATTERNS INFERRED FROM MASSIVE RNA-SEQ DATA
RNA 25(7):rna.070052.118 • April 2019
A – Factor de impacto JCR:4,320 Q2 biochemistry& molecular biology

• You Li, Rachel M Reeves, Xin Wang, Quique Bassat, W Abdullah Brooks, Cheryl Cohen, David P Moore, Marta Nunes, Barbara Rath, Harry Campbell, Harish Nair, on behalf of the RSV Global Epidemiology Network and RESCEU investigators* (Martinón-Torres, F)
GLOBAL PATTERNS IN MONTHLY ACTIVITY OF INFLUENZA VIRUS, RESPIRATORY SYNCYTIAL VIRUS, PARAINFLUENZA VIRUS, AND METAPNEUMOVIRUS: A SYSTEMATIC ANALYSIS
Lancet Glob Health. 2019 Aug;7(8):e1031-e1045
A – Factor de impacto JCR: 21,597 – D1 public, environmental & occupational health

• Justicia-Grande, AJ; Martinon-Torres, F
THE RESVINET SCORE FOR BRONCHIOLITIS: A SCALE FOR ALL SEASONS
Am J Perinatol 2019; 36(S 02): S48-S53
A – Factor de impacto JCR:1,474- Q3 obstetrics&gynecology

• Marco Aurelio P. Safadi, Federico Martinon-Torres, Lily Yin Weckx, Edson Duarte Moreira Junior, Eduardo Jorge da Fonseca Lima, Arnold Willemsen, Daniela Toneatto, Md Ahsan Habib, DorotaBorys
IMMUNOGENICITY OF THE PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE (PHID-CV) ADMINISTERED CONCOMITANTLY WITH THE MENINGOCOCCAL SEROGROUP B (4CMENB) VACCINE IN INFANTS: A POST-HOC ANALYSIS IN A PHASE 3B, RANDOMISED, CONTROLLED TRIAL
Vaccine. 2019 Aug 14;37(35):4858-4863
A – Factor Impacto JCR: 3,143 – Q1-Immunology

• Federico Martinón-Torres, Xavier Bosch, Rino Rappuoli, ShamezLadhani, Esther Redondo, Timo Vesikari, Adolfo García-Sastre, Irene Rivero-Calle, José Gómez-Rial, Antonio Salas, Carlos Martín, Adam Finn &Robb Butler
TIPICO IX: REPORT OF THE 9TH INTERACTIVE INFECTIOUS DISEASE WORKSHOP ON INFECTIOUS DISEASES AND VACCINES
Hum VaccinImmunother. 2019;15(10):2405-2415
A – Factor Impacto JCR: 2,619– Q2: biotechnology & applied microbiology

• Abad, R; Martinon-Torres, F; Santolaya, ME; Banzhoff, A; Gonzalez-Inchausti, C; Grana, MG; Vazquez, JA
FROM A PATHOGEN’S GENOME TO AN EFFECTIVE VACCINE: THE FOUR-COMPONENT MENINGOCOCCAL SEROGROUP B VACCINE
Rev EspQuimioter, 2019 Jun, 32 (3): 208-2016
A – Factor Impacto JCR: 1,132 Q4 Microbiology

• Perrett, K; Garcia, IC; Halperin, S; Nolan, T; Virta, M; Stranak, Z; Surico, D; Kostanyan, L; Ceregido, MA; Kuriyakose, S; Cheuvart, B; Meyer, N; Pancorbo, CM; Fernandez, MM; Martinon-Torres, F; Zambano, MAR; Vanderkooi, O; Kosina, P; Garcia, AM; Pardilla, MBE; Marin, MDC; de la Fuente, JFA; Fernandez-Miranda, MD; Splinter, K; Espinar,YR; Zuccotti, GV; Marchisio, PG; Manzoni, P; Mesaros, N
PERTUSSIS VACCINATION DURING PREGNANCY: A MULTI-COUNTRY RANDOMISED PLACEBO-CONTROLLED TRIAL ASSESSING IMMUNOGENICITY AND SAFETY OF DTPA IN MOTHERS AND THEIR INFANTS
Bjog-an international journal of obstetrics and gynaecology, 2019 Jun, 126 (2): 173-174
A – Factor Impacto JCR: 4,663 Q1-D1 obstetrics&gynecology

• Sulleiro E, Frick MA , Rodó C , Espasa M , Thorne C , Espiau M , Martín-Nalda A , Suy A , Giaquinto C , Melendo S , Rando A , Alarcón A , Martinón-Torres F , Pumarola T , Soler-Palacín P , Soriano-Arandes A .
THE CHALLENGE OF THE LABORATORY DIAGNOSIS IN A CONFIRMED CONGENITAL ZIKA VIRUS SYNDROME IN UTERO: A CASE REPORT.
Medicine (Baltimore). 2019 May;98(20):e15532
A – Factor Impacto JCR: 1,552 Q3- Medicine, General &Internal

• Salas, A; Pardo-Seco, J; Cebey-Lopez, M; Martinon-Martinez, JM; Gomez-Rial, J; Curras-Tuala, MJ; Pischedda, S; Barral-Arca, R; Justicia-Grande, A; Rivero-Calle, I; Vilar J, Martinón-Torres F
IMPACT OF ROTAVIRUS VACCINATION ON CHILDHOOD HOSPITALIZATIONS FOR SEIZURES: HETEROLOGOUS OR UNFORESEEN DIRECT VACCINE EFFECTS?
Vaccine, 2019 May, 37 (25): 3362-3368
A – Factor Impacto JCR: 3,143 Q2 Immunology

• Redondo, E; Rivero-Calle, I; Mascaros, E; Diaz-Maroto, JL; Linares, M; Gil, A; Molina, J; Jimeno, I; Ocana, D; Yuste, JE; Martinon-Torres, F
THE NEW OFFICIAL VACCINE CALENDAR FOR ADULTS DOES NOT INCLUDE THE PREVENTION OF PNEUMOCOCCAL PNEUMONIA
Rev EspQuimioter, 2019 Jun, 32 (3): 281-283
A – Factor Impacto JCR: 1,132 Q4 Pharmacology and Toxicology

• Elisa Fernandez-CookeI, Ana Barrios Tasco,, Judith Sa´nchez-Manubens, Jordi Antón, Carlos Daniel Grasa LozanoI, Javier Aracil Santos, Enrique Villalobos Pinto,, Daniel Clemente Garulo, Beatriz Mercader Rodríguez, Matilde Bustillo Alonso, Esmeralda Nuñez Cuadros, Maria Luisa Navarro Gómez, Sara Domínguez Rodríguez, Cristina Calvo, onbehalfofthe KAWA-RACE studygroup (Martinón-Torres, F; Rivero Calle, I, Justicia Grande, A)
EPIDEMIOLOGICAL AND CLINICAL FEATURES OF KAWASAKI DISEASE IN SPAIN OVER 5 YEARS AND RISK FACTORS FOR ANEURYSM DEVELOPMENT. (2011-2016): KAWA-RACE STUDY GROUP
PLOS ONE, 2019 May, 14 (5), e0215665
A – Factor de impacto JCR: 2,740 Q2 Multidisciplinary

• Lisa Borghini, Eileen Png, Alexander Binder, Victoria J. Wright, ElliePinnock, Ronald de Groot, Jan Hazelzet, MariekeEmonts, Michiel Van derFlier, Luregn J. Schlapbach, Suzanne Anderson, FatouSecka, Antonio Salas, Colin Fink, Enitan D. Carrol, Andrew J. Pollard, Lachlan J. Coin, Taco W. Kuijpers, Federico Martinon-Torres, Werner Zenz, Michael Levin, Martin L. Hibberd, Sonia Davila& EUCLIDS consortium
IDENTIFICATION OF REGULATORY VARIANTS ASSOCIATED WITH GENETIC SUSCEPTIBILITY TO MENINGOCOCCAL DISEASE
Scientific Reports (2019) 9:6966
A – Factor Impacto JCR: 3,998 – Q1 Multidisciplinary

• Nicola Cotugno , Alessandra Ruggiero , VeronicaSantilli, Emma ConcettaManno, Salvatore Rocca , Sonia Zicari, Donato Amodio , Manuela Colucci , Paolo Rossi, Ofer Levy, Federico Martinon-Torres , Andrew J. Pollard, and Paolo Palma
OMIC TECHNOLOGIES AND VACCINE DEVELOPMENT: FROM THE IDENTIFICATION OF VULNERABLE INDIVIDUALS TO THE FORMULATION OF INVULNERABLE VACCINES
Journal of Immunology Research 2019(4):1-10
A – Factor de impacto JCR: 3,327 Q3 Inmunology

• Jose Gómez-Rial, Sonia Sánchez-Batá, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres,
FURTHER CONSIDERATIONS ON ROTAVIRUS VACCINATION AND SEIZURE-RELATED HOSPITALIZATION RATES
Infection and Drug Resistance 2019:12 989–991
A – Factor de impacto JCR: 2,984 – Q2 – Infectious Diseases

• Javier Díez-Domingo, María Garcés-Sánchez, Francisco Giménez-Sánchez, Javier Colomina-Rodríguez y Federico Martinón-Torres
¿QUÉ HEMOS APRENDIDO SOBRE ROTAVIRUS EN ESPAÑA EN LOS ÚLTIMOS 10 AÑOS?
An Pediatr (Barc). 2019 Sep;91(3):166-179
A – Factor de impacto JCR: 1,313 Q3 Pediatrics

• Carolina López-Sanguos, Irene Rivero Calle, Carmen RodriguezTenreiro, Peter Francis Raguindin and Federico Martinón-Torres
SAFETY AND IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINES IN PRETERM INFANTS
Expert Opin Drug Saf. 2019 Apr;18(4):253-259
A – Factor Impacto JCR: 3,383 Q1 Pharmacology and Pharmacy

• Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellanoc, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, MariaTheodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan, Iris De Bruijn, forthe GQM05 StudyGroup
EFFICACY, IMMUNOGENICITY, AND SAFETY OF A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN CHILDREN AGED 6–35 MONTHS: A MULTI-SEASON RANDOMISED PLACEBO-CONTROLLED TRIAL IN THE NORTHERN AND SOUTHERN HEMISPHERES
Vaccine. 2019 Mar 22;37(13):1876-1884.
A – Factor Impacto JCR: 3,143 – Q2-Immunology

• Vana Spoulou, Sophie Alain, Giovanni Gabutti, Carlo Giaquinto, Johannes Liese, Federico Martinon-Torres and Timo Vesikari
IMPLEMENTING UNIVERSAL VARICELLA VACCINATION IN EUROPE: THE PATH FORWARD
Pediatr Infect Dis J. 2019 Feb;38(2):181-188
A – Factor de impacto JCR:2,126– Q2 -Pediatrics

• Federico Martinόn-Torres, Javier Diez-Domingo, Emmanuel Feroldi, Emilia Jordanov, SihamB’Chir, and Xavier Da Costa, Hospital Clinico Universitario de Santiago de Compostela, Spain;FISABIO-PublicHealth,Valencia, Spain; Sanofi Pasteur, France; Sanofi Pasteur, USA
EVALUATION OF A HEXAVALENT-PENTAVALENT-HEXAVALENT INFANT PRIMARY VACCINATION SERIESFOLLOWED BY A PENTAVALENT BOOSTER VACCINE IN HEALTHY INFANTS AND TODDLERS
The Pediatric Infectious Disease Journal 2019;38:317–322
A – Factor de impacto JCR:2,126– Q2- Pediatrics

• Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres, Pollard AJ, Růžková R, Martinez AC, Ulied A, Valdivieso MM, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK.
ANAMNESTIC IMMUNE RESPONSE AND SAFETY OF AN INACTIVATED QUADRIVALENT INFLUENZA VACCINE IN PRIMED VERSUS VACCINE-NAÏVE CHILDREN
Pediatr Infect Dis J. 2019 Feb;38(2):203-210.
A – Factor de impacto JCR:2,126– Q2 – Pediatrics

• Grasa CD, Fernandez-Cooke E, Sánchzez-Manubens J, Antón J, Crespo D, García M, López A, Lirola Cruz MJ, Díaz-Delgado de la Peña r, Calvo C, Spanishnetworkforthestudyof Kawasaki disease. KAWA-RACE
KAWASAKI DISEASE IN INFANTS 3 MONTHS OF AGE AND YOUNGER: A MULTICENTRE SPANISH STUDY
Ann Rheum Dis.2019 Feb;78(2):289-290
A – Factor de impacto JCR: 16,102 Q1 – D1 Rheumatology

• Micaela Gal, Nina Gobat, Nicholas A. Francis, Kerenza Hood, Christopher C. Butler, Julia Bielicki, Pieter L. Fraaij, Mike Sharland, Jessica Jarvis, Annemarie M.C. van Rossum, TerhoHeikkinen, Federico Martinon-Torres, JethroHerberg, Angela Watkins, Steve A.R. Webb, Ronnie Moore, PrasanthSukumar, and AlistairNichol
PRIORITY NEEDS FOR CONDUCTING PANDEMIC-RELEVANT CLINICAL RESERACH WITH CHILDREN IN EUROPE: A CONSENSUS STUDY WITH PEDIATRIC CLINICIAN-RESEARCHERS.
PediatrInfectDis J. 2019 May;38(5): e82-e86
A – Factor de impacto JCR:2,126– Q2- Pediatrics

• Alfredo Cano-Garcinuño, Manuel Praena-Crespo, Isabel Mora-Gandarilla, Ignacio Carvajal-Urueña, María Teresa Callén-Blecua, Águeda García-Merino, Grupo de Expertos para el Diagnóstico de la Bronquiolitis (Martinon-Torres, F)
CRITERIA HETEROGENEITY IN THE DIAGNOSIS OF ACUTE BRONCHIOLITIS IN SPAIN
Anales de Pediatría, 2019 Feb 90 (2): 109-117
A – Factor de impacto JCR: 1,313 Q3 Pediatrics

• Cristina Calvo, Talía Sainz, Pilar Codoner-Franch, BegonaSantiago,M. Luz García-García, César García Vera, M. AngelesMunoz-Fernandez,Antonio Pérez-Martínez, Irene Rivero, Cristina FernandezPérez,Asunción Mejías, Federico Martinón-Torres, Fernando Cabanas, Plataforma INVEST-AEP
PAEDIATRIC RESEARCH IN SPAIN: CHALLENGES AND PRIORITIES.INVEST-AEP Platform
AnPediatr (Barc).2018;89: 314. e1-314.e6
A – Factor de impacto JCR: 1,313 Q3 Pediatrics

• Raúl Ortiz de Lejarazu, Javier Díez Domingo, Ángel Gil de Miguel, Federico Martinón Torres, Carlos Guzmán Quilo, José María Guillén, Blanca Piedrafita, Esther Redondo Marguello
DESCRIPCIÓN DE LA GRIPE B EN LAS EPIDEMIAS ESTACIONALES DE ESPAÑA
RevEspQuimioter. 2018 Dec;31(6):511-519
A – Factor de impacto JCR: 1,132 Q4 Pharmacology and Toxicology

• José Gómez-Rial, Sonia Sánchez-Batán, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres
ROTAVIRUS INFECTION BEYOND THE GUT
Infection and Drug Resistance 2018 Dec 24;12:55-64.
A – Factor de impacto JCR: 2,984 – Q2 – InfectiousDiseases

• Victoria J.Wright, Jethro A. Herberg,MyrsiniKaforou, Chisato Shimizu, HarikliaEleftherohorinou, Hannah Shailes, Anouk M. Barendregt, Stephanie Menikou, Stuart Gormley, Maurice Berk, Long Truong Hoang, Adriana H. Tremoulet,John T. Kanegaye, Lachlan J. M. Coin, Mary P. Glodé, Martin Hibberd, TacoW. Kuijpers, Clive J. Hoggart, Jane C. Burns, Michael Levin, FRCPCH; for the Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric
Emergency Medicine Kawasaki Disease Research Group (PEMKDRG)
DIAGNOSIS OF KAWASAKI DISEASE. USING A MINIMAL WHOLE-BLOOD GENE EXPRESSION SIGNATURE
JAMA Pediatrics 2018; 172 (10)
A- Factor de impacto JCR:45,540 Q1- D1 Pediatrics

• Ahonen, Anitta; Berry, Andrea; Chatterjee,Archana; Clifford, Robert; Diaz Perez, Clemente; Diez-Domingo, Javier; Haney, Byron; Harrison, Christopher J;Kerdpanich, AngkoolPhirangkul; Lee, Jimmy KF; Leonardi, Michael; Martinón-Torres, Federico; Miranda,Mariano; Perez Porcuna, Xavier Maria; Phongsamart, Wanatpreeya; Sharifah Huda, EngkuAlwi; Toh, Teck-Hock; Twiggs, Jerry; UliedArminana, Angels; Varman, Meera; Zissman, Edward. GSK Vaccinesstaff: Caplanusi, Adrian; Carryn, Stephane; Henry, Ouzama; Povey, Michael.
IMMUNOGENICITY AND SAFETY OF MEASLES-MUMP-RUBELLA VACCINE AT TWO POTENCY ADMINISTERED TO HEALTHY CHILDREN AGED 12-15 MONTHS:A PHASE III, RANDOMIZED, NON-INFERIORITY TRIAL
Vaccine. 2018 Sep 11;36(38):5781-5788
A – Factor Impacto JCR: 3,143 – Q1-Immunology

• Federico Martinón-Torres, EwaBernatowska, Anna Shcherbina, Susanna Esposito,
Leszek Szenborn, Magda CampinsMarti, Stephen Hughes, Saul N. Faust, Luis I. Gonzalez-Granado, Ly-Mee Yu, Diego D’Agostino, Marco Calabresi, Daniela Toneatto, Matthew D. Snape,
MENINGOCOCCAL B VACCINE IMMUNOGENICITY IN CHILDREN WITH DEFECTS IN COMPLEMENT AND SPLENIC FUNCTION
Pediatrics.2018;141(6):e20174250
A – Factor Impacto JCR: 5,359- Q1-D1 Pediatrics

• Emily Bongard, Alike W van derVelden, Johanna Cook, Ben Saville, Philippe Beutels, Rune MunckAabenhus, CurtBrugman, SlawomirChlabicz, Samuel Coenen, Annelies Colliers, Melanie Davies, Muireann De Paor, An De Sutter, Nick A Francis, Dominik Glinz, MaciekGodycki-ćwirko, Herman Goossens, Jane Holmes, Margareta Ieven, Menno de Jong, Morten Lindbaek, Paul Little, FredericoMartinón-Torres, Ana Moragas, JózsefPauer, MarkétaPfeiferová, Ruta Radzeviciene-Jurgute, Pär-Daniel Sundvall, Antoni Torres, PiaTouboul, DionyssiosVarthalis, Theo Verheij,Christopher C Butler
ANTIVIRALS FOR INFLUENZA-LIKE ILLNESS? A RANDOMISED CONTROLLED TRIAL OF CLINICAL AND COST EFFECTIVENESS IN PRIMARY CARE (ALIC4E): THE ALIC4E PROTOCOL
BMJ Open 2018; Jul 12;8(7) :e021032
A – Factor Impacto JCR: 2,496 Q2 Medicine General &Internal

• Antonio Salas, Jacobo Pardo-Seco, Ruth Barral-Arca, Miriam Cebey-López, Alberto Gómez-Carballa, Irene Rivero-Calle, Sara Pischedda, María-José Currás-Tuala, Jorge Amigo, José Gómez-Rial, Federico Martinón-Torres and onbehalfof GENDRES Network
WHOLE EXOME SEQUENCING IDENTIFIES NEW HOST GENOMIC SUSCEPTIBILITY FACTORS IN EMPYEMA CAUSED BY STREPTOCOCCUS PNEUMONIAE IN CHILDREN: A PILOT STUDY
Genes 2018, 9, 240
A – Factor Impacto JCR: 3,759 Q2 Genetics and Heredity

• Navin P. Boeddha, Luregn J. Schlapbach, Gertjan J. Driessen, Jethro A. Herberg, Irene Rivero-Calle, Miriam Cebey-López, Daniela S. Klobassa, Ria Philipsen, Ronald de Groot, David P. Inwald, Simon Nadel, Stéphane Paulus, Eleanor Pinnock, Fatou Secka, Suzanne T. Anderson, Rachel S. Agbeko, Christoph Berger, Colin G. Fink, Enitan D. Carrol, Werner Zenz, Michael Levin, Michiel van der Flier, Federico Martinón-Torres, Jan A. Hazelzet, Marieke Emonts and on behalf of the EUCLIDS consortium
MORTALITY AND MORBIDITY IN COMMUNITY-ACQUIRED SEPSIS IN EUROPEAN PEDIATRIC INTENSIVE CARE UNITS: A PROSPECTIVE COHORT STUDY FROM THE EUROPEAN CHILDHOOD LIFE-THREATENING INFECTIOUS DISEASE STUDY (EUCLIDS)
Critical Care 2018 22:143
A – Factor Impacto JCR: 6,407 Q1 Critical Care Medicine

• Gomez-Carballa A, Pardo-Seco J, Brandini S, Achilli A, Perego UA, Coble MD, Diegoli TM, Alvarez-Iglesias V, Martinon-Torres F, Olivieri A, Torroni A, Salas A.
THE PEOPLING OF SOUTH AMERICA AND THE TRANS-ANDEAN GENE FLOW OF THE FIRST SETTLERS.
Genome Res. 2018 Jun; 28(6):767-779.
A – Factor Impacto JCR: 11,093 Q1 – D1 Molecular Biology and Genetics

• Federico Martinón-Torres, Antonio Salas, Irene Rivero-Calle, Miriam Cebey-López, Jacobo Pardo-Seco, Jethro A Herberg, Navin P Boeddha, Daniela S Klobassa, Fatou Secka, Stephane Paulus, Ronald de Groot, Luregn J Schlapbach, Gertjan J Driessen, Suzanne T Anderson, Marieke Emonts, Werner Zenz, Enitan D Carrol, Michiel Van der Flier, Michael Levin, on behalf of the show EUCLIDS Consortium
LIFE-THREATENING INFECTIONS IN CHILDREN IN EUROPE (THE EUCLIDS PROJECT): A PROSPECTIVE COHORT STUDY
Lancet Child Adolesc Health. 2018 Jun;2(6):404-414
A – Factor de Impacto JCR: 8,543 – Q1 – D1 Development and educational Psychology

• R. Barral-Arca, J. Pardo-Seco, F. Martinón-Torres & A. Salas
A 2-TRANSCRIPT HOST CELL SIGNATURE DISTINGUISHES VIRAL FROM BACTERIAL DIARRHEA AND IT IS INFUENCED BY THE SEVERITY OF SYMPTOMS
Scientific Reports. 23 Mayo 2018; (8):8043
A – Factor Impacto JCR: 3,998 – Q1:Multidisciplinary

• Martinón-Torres F, Heininger U, Thomson A, Wirsing von König CH
CONTROLLING PERTUSSIS: HOW CAN WE DO IT? A FOCUS ON IMMUNIZATION.
Expert Rev Vaccines. Abril 2018; 17(4):289-297
A – Factor Impacto JCR: 4,362 Q1 Inmunology

• Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, Mejías A, Baraldi E, Papadopoulos NG, Nair H, Nunes MC, Kragten-Tabatabaie L, Heikkinen T, Greenough A, Stein RT, Manzoni P, Bont L, Martinón-Torres F
RESPIRATORY SYNCYTIAL VIRUS SEASONALITY: A GLOBAL OVERVIEW.
J Infect Dis. Abril 2018;217(9):1356-1364
A – Factor Impacto JCR: 5,022 Q1-Medicine

• Claeys C, Drame M, Garcia-Sicilia J, Zaman K, Carmona A, Tran PM, Miranda M, Martinon-Torres F, Thollot F, Horn M, Schwarz TF, Behre U, Merino JM, Sadowska-Krawczenko I, Szymanski H, Schu P, Neumeier E, Li P, Jain VK and InnisBL.
ASSESSMENT OF AN OPTIMIZED MANUFACTURING PROCESS FOR INACTIVATED QUADRIVALENT INFLUENZA VACCINE: A PHASE III, RANDOMIZED, DOUBLE-BLIND, SAFETY AND IMMUNOGENICITY STUDY IN CHILDREN AND ADULTS
BMC Infectious Diseases, 18 Abril 2018;18(1):186
A – Factor Impacto JCR: 2,688 Q2 Inmunology

• Marieke L.A. de Hoog, Timo Vesikari, Carlo Giaquinto, Hans-IkoHuppertz, Federico Martinon-Torres, Patricia Bruijning-Verhagen
REPORT OF THE 5TH EUROPEAN EXPERT MEETING ON ROTAVIRUS VACCINATION (EEROVAC) UTRECHT, THE NETHERLANDS, 20–22 MARCH 2017
Hum VaccinImmunother, 2018 Apr 3;14(4):1027-1034
A – Factor Impacto JCR: 2,619 – Q2:Multidisciplinary

• José Gómez Rial, María José Curras Tuala, Irene Rivero Calle, Carmen Rodríguez-Tenreiro, Lorenzo Redondo Collazo, Alberto Gómez Carballa, Jacobo Pardo-Seco, Antonio Salas, Federico Martinón-Torres
ROTAVIRUS INTESTINAL INFECTION INDUCES AN ORAL MUCOSA CYTOKINE RESPONSE
PLoS ONE 2018 Abril; 13(4): e0195314
A – Factor de Impacto JCR: 2,740 Q2 Multidisciplinary

• CarineClaeys, KhalequZaman, GhassanDbaibo, Ping Li, Allen Izu, Pope Kosalaraksa, Luis Rivera, Beatriz Acosta, Maria Luisa Arroba Basanta, Asma Aziz, Miguel AngelCabanero, VijayalakshmiChandrashekaran, BartholomewCorsaro, Luis Cousin, Adolfo Diaz, Javier Diez-Domingo, EnerCagriDinleyici, Saul N Faust, Damien Friel, JoseGarcia-Sicilia, Grace D Gomez-Go, Maria Liza Antoinette Gonzales, Stephen M Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Ludovic Malvaux, Josep Mares Bermudez, Federico Martinon-Torres, Mariano Miranda, May Montellano, Maria Amor PeixSambola, RomanPrymula, ThanyaweePuthanakit, Renata Ruzkova, IwonaSadowska-Krawczenko, Ignacio Salamanca de la Cueva, EtienneSokal, JyotiSoni, Henryk Szymanski, AngelsUlied, Anne Schuind, Varsha K Jain, Bruce L Innis, forthe Flu4VEC StudyGroup
PREVENTION OF VACCINE-MATCHED AND MISMATCHED INFLUENZA IN CHILDREN AGED 6−35 MONTHS: A MULTINATIONAL RANDOMIZED TRIAL ACROSS FIVE INFLUENZA SEASONS
The Lancet Child & Adolescent Health, 2018 Marzo; 2 (5): 338-349
A – Factor de Impacto JCR: 8,543 – Q1 – D1 Development and educational Psychology

• Soriano-Arandes A, Rivero-Calle I, Nastouli E, Espiau M, Frick MA, Alarcon A, Martinón-Torres F
WHAT WE KNOW AND WHAT WE DON’T KNOW ABOUT PERINATAL ZIKA VIRUS INFECTION: A SYSTEMATIC REVIEW.
Expert Rev Anti Infect Ther. 2018 Marzo; 16(3): 243-254
A – Factor de Impacto JCR: 3,767 – Q2 InfectiousDiseases

• Martinón-Torres F, Carmona Martinez A, Simkó R, Infante Marquez P, Arimany JL5, Gimenez-Sanchez F, Couceiro Gianzo JA, Kovács É, Rojo P, Wang H, Bhusal C, Toneatto D.
ANTIBODY PERSISTENCE AND BOOSTER RESPONSES 24-36 MONTHS AFTER DIFFERENT 4CMenB VACCINATION SCHEDULES IN INFANTS AND CHILDREN: A RANDOMISED TRIAL
J. Infect. 2018 Marzo. 76(3): 258-269
A – Factor Impacto JCR: 4,842- Q1 – Immunology

• U.Toscanini, A.Gaviria, J.Pardo-Seco, A.Gómez-Carballa, F.Moscoso, M.Vela, S.Cobos, A.Lupero, A.K.Zambrano, F.Martinón-Torres, A.Carabajo-Marcillo, R.Yunga-León, N.Ugalde-Noritz, A.Ordoñez-Ugalde, A.Salas
THE GEOGRAPHIC MOSAIC OF ECUADORIAN Y-CHROMOSOME ANCESTRY
Forensic Sci Int: Genet. Marzo 2018;33:59-65
A – Factor Impacto JCR: 4,884 – Q1 – Molecular Biology and Genetics

• Obando-Pacheco P, Rivero-Calle I, Gómez-Rial J, Rodríguez-Tenreiro Sánchez C, Martinón-Torres F
NEW PERSPECTIVES FOR HEXAVALENT VACCINES
Vaccine 36 (2018) 5485-5494
A – Factor Impacto JCR: 3,143 – Q2 – Immunology and Microbiology

• Ting Shi, David A McAllister, Katherine L O’Brien, Eric A F Simoes, Shabir A Madhi, Bradford D Gessner, Fernando P Polack, Evelyn Balsells, SozinhoAcacio, Claudia Aguayo, IssifouAlassani, Asad Ali, Martin Antonio, Shally Awasthi, Juliet O Awori, Eduardo Azziz-Baumgartner, Henry C Baggett, Vicky L Baillie, Angel Balmaseda, Alfredo Barahona, Sudha Basnet, Quique Bassat, Wilma Basualdo, Godfrey Bigogo, Louis Bont, Robert F Breiman, W Abdullah Brooks, Shobha Broor, Nigel Bruce, Dana Bruden, Philippe Buchy, Stuart Campbell, Phyllis Carosone-Link, Mandeep Chadha, James Chipeta, Monidarin Chou, Wilfrido Clara, Cheryl Cohen, Elizabeth de Cuellar, Duc-Anh Dang, Budragchaagiin Dash-yandag, Maria Deloria-Knoll, Mukesh Dherani, TekchhengEap, Bernard E Ebruke, Marcela Echavarria, Carla Cecília de Freitas LázaroEmediato, Rodrigo A Fasce, Daniel R Feikin, Luzhao Feng, Angela Gentile, Aubree Gordon, Doli Goswami, Sophie Goyet, Michelle Groome, Natasha Halasa, Siddhivinayak Hirve, Nusrat Homaira, Stephen R C Howie, Jorge Jara, ImaneJroundi, Cissy B Kartasasmita, Najwa Khuri-Bulos, Karen L Kotloff, Anand Krishnan, Romina Libster, Olga Lopez, Marilla G Lucero, Florencia Lucion, Socorro P Lupisan, Debora N Marcone, John P McCracken, Mario Mejia, Jennifer C Moisi, Joel M Montgomery, David P Moore, CintaMoraleda, Jocelyn Moyes, Patrick Munywoki, KuswandewiMutyara, Mark P Nicol, D James Nokes, PagbajabynNymadawa, Maria Tereza da Costa Oliveira, HistoshiOshitani, Nitin Pandey, GláuciaParanhos-Baccalà, Lia N Phillips, Valentina Sanchez Picot, Mustafizur Rahman, Mala Rakoto-Andrianarivelo, Zeba A Rasmussen, Barbara A Rath, Annick Robinson, Candice Romero, Graciela Russomando, Vahid Salimi, PongpunSawatwong, Nienke Scheltema, Brunhilde Schweiger, J Anthony G Scott, Phil Seidenberg, KunlingShen, Rosalyn Singleton, Viviana Sotomayor, Tor A Strand, AgustinusSutanto, Mariam Sylla, Milagritos D Tapia, SomsakThamthitiwat, Elizabeth D Thomas, RafalTokarz, Claudia Turner, Marietjie Venter, SunthareeyaWaicharoen, Jianwei Wang, WanitdaWatthanaworawit, Lay-Myint Yoshida, Hongjie Yu, Heather J Zar, Harry Campbell, Harish Nair†, for RSV Global Epidemiology Network
GLOBAL, REGIONAL, AND NATIONAL DISEASE BURDEN ESTIMATES OF ACUTE LOWER RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS IN YOUNG CHILDREN IN 2015: A SYSTEMATIC REVIEW AND MODELLING STUDY
Lancet 2017; 390: 946–58
A – Factor de Impacto JCR: 60,392 – D1 – Medicine, General & Internal

• Markus Chan, John J Park, Ting Shi, Federico Martinón-Torres, Louis Bont, Harish Nair in collaboration with Respiratory Syncytial Virus Network (ReSViNET)
THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS (RSV) ASSOCIATED ACUTE LOWER RESPIRATORY INFECTIONS IN CHILDREN WITH DOWN SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
Journal of Global Health. Diciembre 2017, 7(2): 020413
A – Factor Impacto JCR: 2,899 – Q2 – Health Policy

• Justicia Grande A, Pardo Seco J, Rivero Calle I, Martinón-Torres F
CLINICAL RESPIRATORY SCALES: WHICH ONE SHOULD WE USE?
Expert Rev. Respir. Med., diciembre 2017; 11(12): 925-943
A – Factor de Impacto JCR: 2,725 – Q2 – RespiratorySystem

• Antonio Salas, Jacobo Pardo Seco, Miriam Cebey López, Alberto Gómez Carballa, Pablo Obando Pacheco, Irene Rivero Calle, María José Curras Tuala, Jorge Amigo, José Gómez Rial, Federico Martinón-Torres &Onbehalfof GENDRES network (www.gendres.org)
WHOLE EXOME SEQUENCING REVEALS NEW CANDIDATE GENES IN HOST GENOMIC SUSCEPTIBILITY TO RESPIRATORY SYNCYTIAL VIRUS DISEASE
Scientific Reports Nov 2017; 7(1): 15888
A – Factor Impacto JCR: 3,998- Q1:Multidisciplinary

• M. Sanchez-Luna, R. Burgos-Pol, I. Oyagüez , J. Figueras-Aloy , M. Sánchez-Solís, F. Martinón-Torres and X. Carbonell-Estrany
COST-UTILITY ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION PROPHYLAXIS IN PRETERM INFANTS: UPDATE BASED ON THE CLINICAL EVIDENCE IN SPAIN
BMC Infectious Diseases Oct 2017; 17(1): 687
A – Factor Impacto JCR: 2,688 – Q2 – Immunology

• S. Pischedda, R. Barral-Arca, A. Gómez-Carballa, J. Pardo-Seco, M.L. Catelli, V. Alvárez-Iglesias, J.M. Cárdenas, N.D. Nguyen, H.H. Ha, A.T. Le, F. Martinón-Torres, C. Vullo y A. Salas
PHYLOGEOGRAPHIC AND GENOME-WIDE INVESTIGATIONS OF VIETNAM ETHNIC GROUPS REVEAL SIGNATURES OF COMPLEX HISTORICAL DEMOGRAPHIC MOVEMENTS
ScientificReports 3 octubre de 2017; 7(1): 12630
A – Factor Impacto JCR: 3,998- Q1:Multidisciplinary

• TinAung, Mineo Ozaki, Mei Chin Lee, UrsulaSchlötzer-Schrehardt, GudmarThorleifsson, TakanoriMizoguchi, Robert P. IgoJr, AravindHaripriya, Susan E Williams, Yury Astakhov, Andrew C Orr, Kathryn P Burdon, SatokoNakano, Kazuhiko Mori, Khaled Abu-Amero, Michael Hauser, Zheng Li, GopalakrishnanPrakadeeswari, Jessica N Cooke Bailey, Alina Popa Chereceanu, Jae H Kang, Sarah Nelson, Ken Hayashi, Shin-IchiManabe, ShigeyasuKazama, Tomasz Zarnowski, Kenji Inoue, Murat Irkec, Miguel Coca-Prados, Kazuhisa Sugiyama, Irma Järvelä, Patricio Schlottmann, S Fabian Lerner, HasnaaLamari, YildirimNilgün, MukharramBikbov, Ki Ho Park, Son CheolCha, Kenji Yamashiro, Juan C Zenteno, Jost B Jonas, Rajesh S Kumar, Shamira A Perera, Anita S Y Chan, Nino Kobakhidze, Ronnie George, LingamVijaya, Tan Do, Deepak P Edward, Lourdes De Juan Marcos, Mohammad Pakravan, SasanMoghimi, Ryuichi Ideta, Daniella Bach-Holm, Per Kappelgaard, Barbara Wirostko, Samuel Thomas, Daniel Gaston, Karen Bedard, Wenda L Greer, Zhenglin Yang, Xueyi Chen, Lulin Huang, JinghongSang, Hongyan Jia, Liyun Jia, ChuyanQuiao, Hui Zhang, Xuyang Liu, Bowen Zhao, Ya-Xing Wang, LiangXu, StéphanieLeruez, Pascal Reynier, George Chichua, SergoTabagari, SteffenUebe, Matthias Zenkel, Daniel Berner, Georg Mossböck,NicolWisschuh, Ursula Hoja, Ulrich.ChristophWelge-Luessen,Christian Mardin, PanayiotaFounti, Anti Chatzikyriakidou, TheofanisPappas, EleftheriosAnastasopoulos, AlexandrosLambropoulos, Arkasubhra Ghosh, RohitShetty, Natalia Porporato, VijayanSaravanan, RengaraiVenkatesh, ChandrashekaranShivkumar, NarendranKalpana, SripriyaSarangapani, Mozhgan R Kanavi, AfsanehNaderi Beni, ShahinYazdani,AlirezaLashay, HomaNaderifar, NassimKhatibi, Antonio Fea, Carlo Lavia, Laura Dallorto, Teresa Rolle, Paolo Frezzotti, Daniela Paoli, Erika Salvi, Paolo Manunta, Yosai Mori, KazunoriMiyata, TomomiHigashide, EtsuoChihara, Satoshi Ishiko, Akitoshi Yoshida, MasahideYanagi, YoshiakiKiuchi, TsutomuOhashi, ToshiyaSakurai, Takako Sugimoto, Hideki Chuman, Makoto Aihara, MasaruInatani, MasahiroMiyake, NorimotoGotoh, FumihikoMatsuda, NagahisaYoshimura, Yoko Ikeda, MorioUeno, ChieSotozono, Jin Wok Jeoung, Min Sagong, KyuHyung Park, JeeyunAhn, Marisa Cruz-Aguilar, Sidi M Ezzouhairi, AbderrahmanRafei, YaanFun Chong, SiaoYu Ng, Shuang Ru Goh, Yueming Chen, Victor H K Yong, Muhammad Imran Khan, Olusola O Olawoye, Adeyinka O Ashaye, IdakwoUgbede, AdeolaOnakoya, NkiruKizor-Akaraiwe, ChaiwatTeekhasaenee, Yanin Suwan, WasuSupakontasan, SuhanyaOkeke, Nkechi J Uche, IfeomaAsimadu, Humaira Ayub, Farah Akhtar, EwaKosior-Jarecka, UrszulaLukasik, Ignacio Lischinsky, Vania Castro, Rodolfo Pérez Grossmann, Gordana SunaricMegevand, Sylvain Roy, Edward Dervan, Eoin Silke, Aparna Rao, PritiSahay, Pablo Fornero, Osvaldo Cuello, Delia Sivori, Tamara Zompa, Richard A Mills, Emmanuelle Souzeau, Paul Mitchell, Jie Jin Wang, Alex W Hewitt, Michael Coote, Jonathan G Crowston, Sergei Y Astakhov, Eugeny L Akopov, Antonemelyanov, Vera Vysochinskaya, GyulliKazakbaeva, RinatFayzrakhmanov, Saleh A Al-Obeidan, OhoudOwaidhah, Leyla Ali Aljasim, MalramChowbay, Jia Nee Foo, Raphael Q Soh, KarSeng Sim, ZhichengXie, Augustine W O Cheong, Shi QiMok, Hui MengSoo, Xiao Yin Chen, Su Qin Peh, KhaiKoonHeng, RahatHusain, Su-Ling Ho, Axel M Hillmer, Ching-Yu Cheng, Francisco A Escudero-Domínguez, Rogelio González-Sarmiento, Federico Martinón-Torres, Antonio Salas Ellacuriaga, KessaraPathanapitoon, Linda Hansapinyo, BoonsongWanichwecharugruang, NarisKitnarong, AnavajSakuntabhai, Hip X Nguyn, Giang T TNguyn, Tình V Nguyn, Werner Zenz, Alexander Binder, Daniela S Klobassa, Martin L Hibberd, Sonia Davila, Stefan Herms, Markus M Nöthen, SusanneMoebus, Robyn M Rautenbach, Ari Ziskind, Trevor R Carmichael, Michele Ramsay, Lydia Álvarez, Montserrat García, Héctor González-Iglesias, Pedro R Rodríguez-Calvo, Luis Fernández-Vega Cueto, ÇilingirOguz, NevbaharTamcelik, Eray Atalay, BilgeBatu, DilekAktas, BurcuKasim, M Roy Wilson, Anne L Coleman, Yutao Liu, Pratap Challa, León Herndon, Rachel W Kuchtey, John Kuchtey, Karen Curtin, Craig J Chaya, Alan Crandall, Linda M Zangwill, Tien Yin Wong, MasakazuNakano, Shigeru Kinoshita, Anneke I Den Hollander, EijaVesti, John H Fingert, Richard K Lee, Arthur J Sit, Bradford J Shingleton, Ningli Wang, Daniele Cusi, RaheelQamar, Peter Kraft, Margaret A Pericak-Vance, SoumyaRaychaudhuri, SteffenHeegaard, Tero Kivelä, André Reis, Friedrich E Kruse, Robert N Weinreb, Louis R Pasquale, Jonathan L Haines, UnnurThorsteinsdottir, FridbertJonasson, R Rand Allingham, Dan Milea, Robert Ritch, Toshiaki Kubota, Kei Tashiro, Eranga N Vithana, ShaziaMicheal, FotisTopouzis, Jamie E Craig, Michael Dubina, PeriasamySundaresan, Kari Stefansson, Janey L Wiggs, Francesca Pasutto&ChieaChuenKhor
GENETIC ASSOCIATION STUDY OF EXFOLIATION SYNDROME IDENTIFIES A PROTECTIVE RARE VARIANT AT LOXL1 AND FIVE NEW SUSCEPTIBILITY LOCI
Nat Genet. 2017 Jul; 49(7):993-1004
A – Factor Impacto JCR: 27,603 – D1 –Genetics&Heredity

• Martinón-Torres F,BoisnardF,ThomasS,SadorgeC,Borrow R;PRI02C studygroup.
IMMUNOGENICITY AND SAFETY OF A NEW HEXAVALENT VACCINE (DTaP5-IPV-HB-Hib) ADMINISTERED IN A MIXED PRIMARY SERIES SCHEDULE WITH A PENTAVALENT vaccine (DTaP5-IPV-Hib)
Vaccine. 2017 Jun 27; 35(30):3764-3772
A – Factor Impacto JCR: 3,143- Q2 – Immunology and Microbiology

• Martinón-Torres F, Safadi MAP, Martinez AC, Marquez PI, Torres JCT, Weckx LY, Moreira ED Junior,MensiI,Calabresi M, Toneatto D
REDUCED SCHEDULES OF 4CMenB VACCINE IN INFANTS AND CATCH-UP SERIES IN CHILDREN: IMMUNOGENICITY AND SAFETY RESULTS FROM A RANDOMISED OPEN-LABEL PHASE 3B TRIAL
Vaccine. 2017 Jun 16; 35(28):3548-3557
A – Factor Impacto JCR: 3,143 – Q2 – Immunology and Microbiology

• J. Gómez-Rial, M.J. CurrásTuala, C. Rodríguez-Tenreiro, L. Vilanova-Trillo, A. Gómez-Carballa, I. Rivero-Calle, A. Justicia-Grande, J. Pardo-Seco, L. Redondo-Collazo, A. Salas, F. Martinón-Torres
SALIVARY EPIDERMAL GROWTH FACTOR CORRELATES WITH HOSPITALIZATION LENGTH IN ROTAVIRUS INFECTION
BMC Infectious Diseases, Mayo 2017; 17(1):370
A – Factor Impacto JCR: 2,688 – Q2 – Immunology

• Fink EL, Kochanek P, Tasker RC, Beca J, Bell MJ, Clark RS, Hutchinson J, Vavilala MS, Fabio A, Angus DC, Watson RS, on behalf of the Prevalence of Acute critical Neurological Disease in Children: A Global Epidemiological Assessment (PANGEA) Investigators, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, and Pediatric Neurocritical Care Research Group (PNCRG) (Martinón-Torres F)
INTERNATIONAL SURVEY OF CRITICALLY ILL CHILDREN WITH ACUTE NEUROLOGIC INSULTS: THE PREVALENCE OF ACUTE CRITICAL NEUROLOGICAL DISEASE IN CHILDREN: A GLOBAL EPIDEMIOLOGICAL ASSESSMENT STUDY
PediatricCritical Care Medicine 2017 Abril; 18(4): 330-342
A – Factor Impacto JCR: 2,854 – Q1 – Pediatrics

• Martinón-Torres F, Greenberg D, Varman M, Killar JA, Hille D, Strable EL, Stek JE, and Kaplan SS
SAFETY, TOLERABILITY AND IMMUNOGENICITY OF PENTAVALENT ROTAVIRUS VACCINE MANUFACTURED BY A MODIFIED PROCESS
PediatrInfectDis J. 2017 Abril; 36(4):417-422
A – Factor Impacto JCR: 2,126– Q2 – Immunology

• P. Safadi MA, Martinon-Torres F, Yin Weckx L, Duarte Moreira Junior E, da Fonseca Lima EJ, Mensi I, Calabresi M, Toneatto D
IMMUNOGENICITY AND SAFETY OF CONCOMITANT ADMINISTRATION OF MENINGOCOCCAL SEROGROUP B (4CMenB) AND SEROGROUP C (MenC-CRM) VACCINES IN INFANTS: A PHASE 3B, RANDOMIZED CONTROLLED TRIAL
Vaccine. 2017 Abril 11; 35(16):2052-2059
A – Factor Impacto JCR: 3,143 -Q2 – Immunology and Microbiology

• F. Martinón-Torres, J. Wysocki, K. J. Center, H. Czajka, E. Majda-Stanislawska, F. Omeñaca, A. Concheiro-Guisan, F. Gimenez-Sanchez, L. Szenborn, D. Blázquez-Gamero, L. Moreno-Galarraga, P. C. Giardina, G. Sun, W. C. Gruber, D. A. Scott and A. Gurtman
CIRCULATING ANTIBODY 1 AND 2 YEARS AFTER VACCINATION WITH THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PRETERM COMPARED WITH TERM INFANTS
Pediatric Infectious Disease Journal 2017 Marz, 36 (3): 326-332
A – Factor Impacto JCR: 2,126– Q2 – Immunology

• Zhang R, Knapp M, Suzuki K, Kajioka D, Schmidt JM, Winkler J, Yilmaz O, Pleschka M, Cao J, Clementson Kockum C, Barker G, Holmdahl G, Beaman G, Keene D, Woolf AS, Cervellione RM, Wei Cheng, Wilkins S, Gearhart JP, Sirchia F, Di Grazia M, Ebert AK, Rösch W, Ellinger J, Jenetzky E, Zwink N, Feitz WF, Marcelis C, Schumacher J, Martinón-Torres F, Lloyd Hibberd M,Chuen Khor C, Heilmann-Heimbach S, Barth S, Boyadjiev SA, Brusco A, Ludwig M, Newman W, Nordenskjöld A, YamadaG, Odermatt B, Reutter H
ISL1 IS A MAJOR SUSCEPTIBILITY GENE FOR CLASSIC BLADDER EXSTROPHY AND A REGULATOR OF URINARY TRACT DEVELOPMENT
ScientificReports 2017. 2017 Feb 8; 7:42170.
A – Factor de Impacto JCR: 3,998- Q1- Multidisciplinary

• Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Lee S, Perez JL, on behalf of the 6108A12001 Study Investigators
MENINGOCOCCAL SEROGROUP B-SPECIFIC RESPONSES AFTER VACCINATION WITH BIVALENT rLP2086: 4 YEAR FOLLOW-UP OF A RANDOMISED, SINGLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 TRIAL
Lancet Infect Dis. 2017 Ene; 17(1):58-67
A – Factor Impacto JCR: 24,446 – D1 – Immunology

• I. Rivero-Calle, J. Pardo-Seco, P. Aldaz, D. A. Vargas, E. Mascarós, E. Redondo, J. L. Díaz-Maroto, M. Linares-Rufo, M. J. Fierro-Alacio, A. Gil, J. Molina, D. Ocaña, Federico Martinón-Torres and onbehalfof NEUMOEXPERTOS group
ERRATUM TO: INCIDENCE AND RISK FACTOR PREVALENCE OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS IN PRIMARY CARE IN SPAIN (NEUMO-ES-RISK PROJECT)
BMC Infect dis. 2017 Ener 12; 17(1):64
A – Factor Impacto JCR: 2,688 – Q2 – Immunology

• Gómez-Carballa A, Pardo-Seco J, Martinón-Torres F, Salas A
PHYLOGENETIC AND POPULATION-BASED APPROACHES TO MITOGENOME VARIATION DO NOT SUPPORT ASSOCIATION WITH MALE INFERTILITY
J Hum Genet. 2017 Mar; 62(3):361-371
A – Factor Impacto JCR: 2,831 – Q2 – Genetics and Heredety

• Nair H, Ramilo O, Eichler I, Pelfrene E, Mejias A, Polack FP, Pouwels KB, Langley JM, Nunes M, van der Maas N, Kragten-Tabatabaie L, Baraldi E, Heikkinen T, Fauroux B, Sharland M, Park C, Manzoni P, Papadopoulos NG, Martinón-Torres F, Stein R, Bont L, Respiratory Syncytial Virus Network (ReSViNET)
MEETING REPORT: HARMONIZATION OF RSV THERAPEUTICS – FROM DESIGN TO PERFORMANCE
Journal of Global Health 2016. 6(1): 010205
A – Factor de Impacto JCR: 2,899 – Q1 – Health Policy

• Martinón-Torres F, Png E, Khor CC, Davila S, Wright VJ, Vega A, Fachal L, Inwald D, Nadel S, Carrol ED, Martinón-Torres N, Alonso SM, Carracedo A, Morteruel E, López-Bayón J, Torre AC, Monge CC, de Aguilar PA, Torné EE, Martínez-Padilla MD, Martinón-Sánchez JM, Levin M, Hibberd ML, Salas A, SIGEM network, ESPID meningococcal consortium – UK, EUCLIDS consortium members – Imperial College London
NATURAL RESISTANCE TO MENINGOCOCCAL DISEASE RELATED TO CFH LOCI: META-ANALYSIS OF GENOME-WIDE ASSOCIATION STUDIES.
Scientific Reports 2016 Nov 2; 6:35842
A – Factor de Impacto JCR: 3,998-Q1:Multidisciplinary

• Rivero Calle I, Pardo Seco J, Aldaz P, Vargas PA, Mascarós E, Redeondo E, Díaz Maroto JL, Linares Rufo M, Fierro Alacio MJ, Gil A, Molina J, Ocaña O, Martinón-Torres F
INCIDENCE AND RISK FACTOR PREVALENCE OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS IN PRIMARY CARE IN SPAIN (NEUMO-ES-RISK PROJECT)
BMC Infectious Diseases 2016Nov 7; 16(1):645.
A – Factor de Impacto JCR: 2,688 – Q2 – Immunology

• Toscanini U, Martinón-Torres F, Gómez A, Berardi G, Llull C, Pardo-Seco J, Andreatta F, Salas A
GENOMIC CONTINUITY OF ARGENTINEAN MENNONITES
Scientific Reports 2016 Nov 8; 6:36392
A – Factor de Impacto JCR: 3,998 – Q1:Multidisciplinary

• Herberg JA, Kaforou M, Wright VJ, Shailes H, Eleftherohorinou H, Hoggart CJ,
Cebey-Lopez M, Carter MJ, Janes VA, Gormley S, Shimizu C, Tremoulet AH,
Barendregt AM, Salas AS, Kanegaye J, Pollard AJ, Faust SN, Patel S, KuijpersT,Martinon-Torres F, Burns JC, Coin LJM, Levin M, for the IRIS Consortium.
DIAGNOSTIC TEST ACCURACY OF A 2-TRANSCRIPT HOST RNA SIGNATURE FOR DISCRIMINATING BACTERIAL VS VIRAL INFECTION IN FEBRILE CHILDREN
JAMA 23-30 Agos 2016; 316 (8), 835-45
A – Factor de Impacto JCR: 45,540 – D1 – Pediatrics

• Martínez-Blanco B, Martinón-Torres F
COMPROBEMOS TAMBIÉN SI LAS GUÍAS DE PRÁCTICA CLÍNICA SE USAN CORRECTAMENTE Y FUNCIONAN. RESPUESTA DE LOS AUTORES
AnPediatr (Barc). 2016 Aug; 85(2):115
A – Factor de Impacto JCR: 1,313 – Q3 – Pediatrics

• Martínez Blanco B, Martinón-Torres F
IS IT URGENT TO UPDATE THE SPANISH CLINICAL PRACTICE GUIDELINES FOR ACUTE BRONCHIOLITIS MANAGEMENT?
Anales Pediatria (Barc.). Agos 2016; 85(2): 106-8.
A – Factor de Impacto JCR: 1,313 – Q3 – Pediatrics

• Salas A, Marco-Puche G, Triviño JC, Gómez-Carballa A, Cebey-López M, Rivero-Calle I, Vilanova-Trillo L, Rodríguez-Tenreiro C, Gómez-Rial J, Martinón-Torres F
STRONG DOWN-REGULATION OF GLYCOPHORIN GENES: A HOST DEFENSE MECHANISM AGAINST ROTAVIRUS INFECTION
Infection, genetics and evolution, Oct 2016; 44: 403-411
A – Factor de Impacto JCR: 2,773 – Q3 – InfectiousDiseases

• Vicente Plaza Moral, Cesáreo Álvarez Rodríguez, Antonio Gómez-Outes, Fernando Gómez Ruiz, Antolín López Viña, Francisco Javier Pellegrini Belinchón, Javier Plaza Zamora, José Antonio Quintano Jiménez, Santiago Quirce Gancedo,i José Sanz Ortega, Ramona Soler Vilarrasa, José Ramón Villa Asensi, en representación del Comité Ejecutivo de la Guía Española para el Manejo del Asma (GEMA) (Federico Martinón-Torres)
OBSOLETE ANTI-PNEUMOCOCCAL VACCINATION RECOMMENDATIONS IN THE SPANISH GUIDELINES FOR THE MANAGEMENT OF ASTHMA (GEMA 4.0): THE AUTORS REPLY
Arch Bronconeumol. 2016 Aug; 52(8):448
A – Factor de Impacto JCR: 4,957- Q1- Respiratory System

• Barral-Arca R, Pischedda S, Gómez-Carballa A, Pastoriza A, Mosquera-Miguel A, López-Soto M, Martinón-Torres F, Álvarez-Iglesias V, Salas A
META-ANALYSIS OF MITOCHONDRIAL DNA VARIATION IN THE IBERIAN PENINSULA
PLoS ONE; Jul 2016; 11(7): e0159735
A – Factor de Impacto JCR: 2,740 – Q2: Multidisciplinary

• McDonald JU, Karforou M, Clare S, Hale C, Ivanova M, Huntley D, Dorner M, Wright VJ, Levin M, Martinón-Torres F, Herberg JA, Tregoning JS
A SIMPLE SCREENING APPROACH TO PRIORITIZE GENES FOR FUNCTIONAL ANALYSIS IDENTIFIES A ROLE FOR INTERFERON REGULATORY FACTOR 7 IN THE CONTROL OF RESPIRATORY SYNCYTIAL VIRUS DISEASE
mSystems 2016 Jun 28;1(3): e00051-16
A – Factor Impacto JCR: 6,633 – Q1- D1 Microbiology

• Justicia-Grande A, Pardo-Seco J, Cebey-López M, Vilanova-Trillo L, Gómez-Carballa A, Rivero-Calle I, Puente-Puig M, Curros-Novo C, Gómez-Rial J, Salas A, Martinón-Sánchez JM, Redondo-Collazo L, Rodríguez-Tenreiro C, Martinón-Torres F, RespiratorySyncytial Virus network (ReSVinet)
DEVELOPMENT AND VALIDATION OF A NEW CLINICAL SCALE FOR INFANTS WITH ACUTE RESPIRATORY INFECTION: THE RESVINET SCALE
PLoS ONE, 21 Jun 2016; 11(6): e0157665
A – Factor de Impacto JCR: 2,740 – Q2: Multidisciplinary

• Rivero Calle I, Gómez Rial J, Martinón-Torres F
SYSTEMIC FEATURES OF ROTAVIRUS INFECTION
Journal of Infection; Jun 2016; 72 Suppl: S98-S105
A – Factor de Impacto JCR: 4,842 – Q1 – Immunology

• Martinón-Torres F
DECIPHERING THE BURDEN OF MENINGOCOCCAL DISEASE: CONVENTIONAL AND UNDER-RECOGNIZED ELEMENTS
Journal of Adolescent Health; Agos 2016; 59(2 Suppl):S12-20
A – Factor de Impacto JCR: 3,900-Q1 – Public, environmental & occupational health

• Snape MD, Voysey M, Finn A, Bona G, Esposito S, Principi N, Díez-Domingo J, Sokal E, Kieninger D, Prymula R, Kohl I, Barone M, Wang H, Toneatto D, Pollard AJ, for the European Men B vaccine study group, (Martinón-Torres F)
PERSISTENCE OF BACTERICIDAL ANTIBODIES AFTER INFANT SEROGROUP B MENINGOCOCCAL IMMUNIZATION AND BOOSTER DOSE RESPONSE AT 12, 18 OR 24 MONTHS OF AGE
Pediatric Infectious Disease Journal. 2016 Abril;35(4):e113-23.
A – Factor de Impacto JCR: 2,126– Q2 – Immunology

• Cebey-López M, Herberg J, Pardo-Seco J, Gómez-Carballa A, Martinón-Torres N, Salas A, Martinón-Sánchez JM, Justicia A, Rivero-Calle I, Sumner E, Fink C, Martinón-Torres F, GENDRES network
DOES VIRAL CO-INFECTION INFLUENCE THE SEVERITY OF ACUTE RESPIRATORY INFECTION IN CHILDREN?
PLoS ONE; Abr 2016; 11(4): e0152481
A – Factor de Impacto JCR: 2,740 – Q2:Multidisciplinary

• Rivero Calle I, Vilanova Trillo L, Pardo Seco J, Blanco Salvado L, IlladeQuinteiro L, Martinón-Torres F
THE BURDEN OF PEDIATRIC INVASIVE MENINGOCOCCAL DISEASE IN SPAIN (2008-2013)
Pediatric Infectious Disease Journal; Abr 2016; 35(4):407–13
A – Factor de Impacto JCR: 2,126– Q2: Immunology

• Pardo-Seco J, Heinz T, Taboada Echalar P, Martinón-Torres F, Salas A
MAPPING THE GENOMIC MOSAIC OF TWO `AFRO-BOLIVIANS´ FROM THE ISOLATED YUNGAS VALLEYS
Journal of Adolescent Health. 2016Mar 9; 17:207
A – Factor de Impacto JCR: 3,900 – Q1-Molecular Biology and Genetics

• Cebey-López M, Herberg J, Pardo-Seco J, Gómez-Carballa A, Martinón-Torres N, Rivero-Calle I, Justicia A, Redondo L, Martinón-Sánchez JM, Martínez-Padilla MC, Giménez-Sánchez F, Salas A, Martinón-Torres F, GENDRES network
ROLE OF VITAMIN D IN HOSPITALIZED CHILDREN WITH LOWER TRACT ACUTE RESPIRATORY INFECTIONS
J. of Pediatric Gastroenterol.and Nutrition 2016 Mar; 62(3):479-85
A – Factor de Impacto JCR: 2,937 – Q1 – Pediatrics

• Toscanini U, Brisighelli F, Llull C, Berardi G, Gómez A, Andreatta F, Pardo Seco J, Gómez Carballa A, Martinón-Torres F, Álvarez Iglesias V, Salas A
CHARTING THE Y-CHROMOSOME ANCESTRY OF PRESENT-DAY ARGENTINEAN MENNONITES
Journal of Human Genetics.Jun 2016; 61(6): 507-13
A – Factor de Impacto JCR: 2,831– Q2 – Genetics and heredity

• Cebey López M, Pardo Seco J, Gómez Carballa A, Martinón Torres N, Martinón Sánchez JM, Justicia Grande A, Rivero Calle I, Pinnock E, Salas A, Fink C, Martinón-TorresF
BACTEREMIA IN CHILDREN HOSPITALIZED WITH RESPIRATORY SYNCYTIAL VIRUS INFECTION
PlosOne. 2016 Feb; 11(2): e0146599.
A – Factor de Impacto JCR: 2,740 – Q2: Multidisciplinary

• Gómez-Carballa A, Moreno F, Alvarez-Iglesias V, Martinón-Torres F, García-Magariños M, Pantoja-Astudillo JA, Aguirre-Morales E, Bustos P, Salas A
REVEALING LATITUDINAL PATTERNS OF MITOCHONDRIAL DNA DIVERSITY IN CHILEANS
Forensic Science Inertnational-Genetics.Enero 2016; 20:81-88
A – Factor de Impacto JCR: 4,884 – Q1 – D1 – Medicine, Legal

• Gómez-Carballa A, Catelli L, Pardo-Seco J, Martinón-Torres F, Roewer L, Vullo C, Salas A
THE COMPLETE MITOGENOME OF A 500-YEAR-OLD INCA CHILD MUMMY
ScientificReports 12 Nov 2015; 5:16462.
A – Factor de Impacto JCR: 3,998 – Q1:Multidisciplinary

• Rivero Calle I, Rodriguez-Tenreiro Sánchez C, Martinón-Torres F
VACUNAS ANTIMENINGOCÓCICAS. SITUACIÓN EPIDEMIOLÓGICA MUNDIAL Y ESTRATEGIAS DE PREVENCIÓN MEDIANTE LA VACUNACIÓN
EnfermInfeccMicrobiol Clin. 2015; 33(4):257–67
A – Factor Impacto JCR: 1,654 – Q4 – Microbiology

• J Arístegui Fernández, JDíez-Domingo, J Marés BermúdezyFMartinón Torres
VACUNACIÓN FRENTE A LA HEPATITIS B. IMPACTO DE LOS PROGRAMAS DE VACUNACIÓN TRAS 20 AÑOS DE SU UTILIZACIÓN EN ESPAÑA. ¿ES TIEMPO DE CAMBIOS?
EnfermInfeccMicrobiol Clin. 2015; 33(2):113–118
A – Factor Impacto JCR: 1,654 – Q4 – Microbiology

• Mazur NI, Martinón-Torres F, Baraldi E, Fauroux B, Greenough A, Heikkinen T, Manzoni P, Mejias A, Nair H, Papadopoulos NG, Polack FP, Ramilo O, Sharland M, Stein R, Madhi SA, Bont L
LOWER RESPIRATORY TRACT INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS: CURRENT MANAGEMENT AND NEW THERAPEUTICS
Lancet RespirMed, Nov 2015; 3(11): 888–900
A – Factor de Impacto JCR: 25,094 – Q1 – D1 Critical Care Medicine

• de Castro López MJ, Rite-García S, Couce ML, Martinón-Torres F
KANGAROO MOTHER CARE INDUCED ARRYTHMIA
KlinischePädiatrie. Sep 2015; 227(5):299-300
A – Factor de Impacto JCR: 0,882 – Q4 Pediatrics

• Cebey-López M, Herberg J, Pardo-Seco J, Gómez-Carballa A, Martinón-Torres N, Salas A, Martinón-Sánchez JM, Gormley S, Summer E, Fink C, Martinón-Torres F, GENDRES network
VIRAL CO-INFECTIONS IN PEDIATRIC PATIENTS HOSPITALIZED WITH LOWER TRACT ACUTE RESPIRATORY INFECTIONS
PlosOne 2 Sept 2015; 10(9): e0136526.
A – Factor de Impacto JCR: 2,740 –Q2:Multidisciplinary

• Heinz T, Cárdenas JM, Álvarez Iglesias V, Pardo-Seco J, Gómez-Carballa A, Santos C, Taboada-Echalar P, Martinón-Torres F, Salas A
THE GENOMIC LEGACY OF THE TRANSATLANTIC SLAVE TRADE IN THE YUNGAS VALLEY OF BOLIVIA
PlosOne 11 Agos 2015; 10 (8): 0134129.
A – Factor de Impacto JCR: 2,740-Q2:Multidisciplinary

• Pardo Seco J, Cebey-López M, Martinón-Torres N, Salas Ellacuriaga A, Gómez-Rial J, Rodríguez-Tenreiro C, Martinón-Sánchez JM, Martinón-Torres F
IMPACT OF ROTAVIRUS VACCINATION ON CHILDHOOD HOSPITALIZATION FOR SEIZURES
Pediatric Infectious Disease Journal, Jul 2015; 34(7):769-73
A – Factor de Impacto JCR: 2,126. – Q2 – Immunology

• Martinón-Torres F, Czajka H, Center KJ, Wysocki J, Majda-Stanislawska E, Omeñaca F, Bernaola Iturbe E, Blazquez Gamero D, Concheiro-Guisán A, Jimenéz-Sánchez F, Szenborn L, Giardina PC, Patterson S, Gruber WC, Scott DA, Gurtman A
13 – VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN PRETERM VERSUS INFANTS
Pediatrics April 2015; 135(4): e876-86
A – Factor de Impacto JCR: 5,359 – Q1- Pediatrics

• Gómez Carballa A, Pardo Seco J, Amigo Lechuga J, Martinón-Torres F, Salas Ellacuriaga A
MITOGENOMES FROM THE 1000 GENOME PROJECT REVEAL NEW NEAR EASTERN FEATURES IN PRESENT-DAY TUSCANS
PLoS ONE, 18 Mar 2015; 10(3):e0119242
A – Factor de Impacto JCR: 2,740- Q2:Multidisciplinary

• de Castro-López MJ, Pardo-Seco J, Martinón-Torres F,
NON SPECIFIC (HETEROLOGOUS) PROTECTION OF NEONATAL BCG VACCINATION AGAINST HOSPITALIZATION DUE TO RESPIRATORY INFECTION AND SEPSIS
ClinicalInfectiousDiseases, Jun 2015; 60(11): 1611-9
A – Factor de Impacto JCR: 8,313 – Q1 – Immunology

• Sarfatti A, Martinón-Torres F, Nadel S
VACCINE EVALUATION: LESSONS FROM A MENINGOCOCCAL B VACCINE
Archives of Disease in Childhood.Jun 2015; 100(6): 514-6
A – Factor de Impacto JCR: 3,041 – Q1 – Pediatrics

• Martinón-Torres F
WHAT´S WEIGHING DOWN HELIOX?
Lancet Respiratory Medicine, Ene 2015;3(1): 14-5
A – Factor de Impacto JCR: 25,094 – D1 – Critical Care Medicine

• Martinón-Torres F
THE UNBEARABLE LIGHTNESS OF BEING HELIOX
Lancet, Ener 2015; 3: 14-15
A – Factor de Impacto JCR: 60,392 – D1- Medicine, General & Internal

• Gustot T, Felleiter P, Pickkers P, Sakr Y, Rello J, Velissaris D, Pierrakos Ch, Taccone FS, Sevcik P, Moreno Ch, Vincent JL, EPIC II Group of Investigators (Martinón-Torres F)
IMPACT OF INFECTION ON THE PROGNOSIS OF CRITICALLY ILL CIRRHOTIC PATIENTS: RESULTS FROM A LARGE WORLDWIDE STUDY.
Liverinternational.Nov 2014; 34(10): 1496–503
A – Factor de Impacto JCR: 5,175 – Q1 – Gastroenterology&Hepatology

• De Waele J, Lipman J, Sakr Y, Marshall JC, Vanhems P, Barrera Groba C, Leone M, Vincent JL, EPIC II Investigators, (Martinón-Torres F)
ABDOMINAL INFECTIONS IN THE INTENSIVE CARE UNIT: CHARACTERISTICS, TREATMENT AND DETERMINANTS OF OUTCOME.
BMC infectious diseases.Jul 2014; 14:420
A – Factor de Impacto JCR: 2,688 – Q3 – Immunology

• García-Magána C, de Castro-López MJ, Llovo-Taboada J, Curros-Novoa C, Puente-Puiga M, Sánchez-Fauquier A, Martinón-Torres F
CARACTERIZACIÓN MICROBIOLÓGICA DE LAS GASTROENTERITIS AGUDAS VIRALES ATENDIDAS EN UN SERVICIO DE PEDIATRÍA EN UN ÁREA DE ALTA COBERTURA VACUNAL FRENTE A ROTAVIRUS
EnfermInfeccMicrobiol Clin. 2014; 32(4):246–249
A – Factor Impacto JCR: 1,654 – Q3 – Immunology

• Pardo-Seco J, Gómez-Carballa A, Amigo J, Martinón-Torres F, Salas A
A GENOME-WIDE STUDY OF MODERN-DAY TUSCANS: REVISITING HERODOTUS’S THEORY ON THE ORIGIN OF THE ETRUSCANS.
PLoSOne. 2014 Sep 17; 9(9):105920
A – Factor Impacto JCR: 2,740 – Q2 Multidisciplinary

• Federico Martinon-Torres, Francisco Gimenez-Sanchez, Enrique Bernaola-Iturbe,Javier Diez-Domingo, Qin Jiang, John L. Perez
A RANDOMIZED, PHASE 1/2 TRIAL OF THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF BIVALENT RLP2086 MENINGOCOCCAL B VACCINE IN HEALTHY INFANTS
Vaccine 2014 Sep; 32(40):5206-11
A – Factor Impacto JCR: 3,143 – Q2 – Immunology and Microbiology

• Chiara Azzari, Federico Martinón-Torres, Heinz-Josef Schmitt, Ron Dagan
EVOLVING ROLE OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CLINICAL PRACTICE
Pediatr Infect Dis J. 2014 Aug; 33(8):858-64
A – Factor Impacto JCR: 2,126– Q2 – Immunology

• Bont L, Baraldi E, Fauroux B, Greenough A, Heikkinen T, Manzoni P, Martinón-Torres F, Nair H, Papadopoulos NG.
RSV – STILL MORE QUESTIONS THAN ANSWERS.
Pediatr Infect Dis J. 2014 Nov; 33(11): 1177-9
A – Factor Impacto JCR: 2,126– Q2 – Immunology

• Ochoa Sangrador C, González de Dios J; ResearchGroupoftheaBREVIADo Project (Martinon-Torres F).
OVERUSE OF BRONCHODILATORS AND STEROIDS IN BRONCHIOLITIS OF DIFFERENT SEVERITY: BRONCHIOLITIS-STUDY OF VARIABILITY, APPROPRIATENESS, AND ADEQUACY.
AllergolImmunopathol (Madr). 2014 Jul-Aug;42(4):307-15.
A – Factor impacto JCR: 1,276 – Q3 – Immunology

• Montero-Martín M, Inwald David, CarrolEnitan, Martinón-Torres F
PROGNOSTIC MARKERS OF MENINGOCOCCAL DISEASE IN CHILDREN: RECENT ADVANCES AND FUTURE CHALLENGES
Expert Rev. Anti Infect. Ther. 2014; 12(11), 1357–69
A – Factor impacto JCR: 3,767 – Q1:Pharmacology and Toxicology

• Pardo-Seco J, Martinón-Torres F, Salas A
EVALUATING THE ACCURACY OF AIM PANELS AT QUANTIFYING GENOME ANCESTRY
BMC Genomics. 2014 Jun 30; 15:543.
A – Factor impacto JCR: 3,594 – Q2- Genetics and heredity

• Parez N, Giaquinto C, Du Roure C, Martinon-Torres F, Spoulou V, Van Damme P, Vesikari T
ROTAVIRUS VACCINATION IN EUROPE: DRIVERS AND BARRIERS
Lancet Infectious Diseases 2014 May; 14(5):416-25.
R – Factor impacto JCR: 24,446 – D1 Immunology

• Martinon-Torres F
SHOULD THE INDICATION OF PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CHILDREN BE DEFINITIVELY WITHDRAWN?
Clinical Infectious Diseases Jul 2014; 59 (1): 138
L – Factor Impacto JCR: 8,313 – Q1 –D1 Immunology

• Gervaix A, Ansaldi A, Brito-Avô A, Azzari C, Knuf M, Martinón-Torres F, Tuerlinckx D, Htar TT, Syrogiannopoulos G
PNEUMOCOCCAL VACCINATION IN EUROPE: SCHEDULE ADHERENCE
Clin Therapeutics 2014 May; 36(5): 802-812
A – Factor Impacto JCR: 3,119 –Q2 – Pharmacology and Pharmacy

• Gil A, Barranco D, Batalla J, Bayas JM, Campins M, GorrotxategiGorrotxategi P, Lluch J, Martinon-Torres F, Mellado MJ, Moreno-Pérez D, Pérez-Rubio A, Vázquez JA.
FE DE ERRORES DE “PREVENCIÓN DE LA ENFERMEDAD MENINGOCÓCICA POR EL SEROGRUPO B MEDIANTE UNA VACUNA DE 4 COMPONENTES.”
AnPediatr (Barc.) 2014; 80(4):273-274
A – Factor de Impacto JCR: 1,313 – Q3 – Pediatrics

• Gil A, Barranco D, Batalla J, Bayas JM, Campins M, GorrotxategiGorrotxategi P, Lluch J, Martinon-Torres F, Mellado MJ, Moreno-Pérez D, Pérez-Rubio A, Vázquez JA.
PREVENCIÓN DE LA ENFERMEDAD MENINGOCÓCICA POR EL SEROGRUPO B MEDIANTE UNA VACUNA DE 4 COMPONENTES.
AnPediatr 2014; 80(4):259.e1-259e.23
A – Factor de Impacto JCR: 1,313 – Q3 – Pediatrics

• F García-Muñoz Rodrigo; A García-Alix Pérez; J Figueras Aloy; P Saavedra Santana; grupo español SEN1500; (Martinón-Torres F)
NEW POPULATION CURVES IN SPANISH EXTREMELY PRETERM NEONATES
AnPediatr (Barc) . 2014 Aug;81(2):107-14
A – Factor de Impacto JCR: 1,313 – Q3 – Pediatrics

• HåkanHanberger, Massimo Antonelli; Martin Holmbom; Jeffrey Lipman; Peter Pickkers; Marc Leone; Jordi Rello; Yasser Sakr; Sten M Walther; Philippe Vanhems; Jean-Louis Vincent; EPIC II GroupofInvestigators (Martinón-Torres F)
INFECTIONS, ANTIBIOTIC TREATMENT AND MORTALITY IN PATIENTS ADMITTED TO ICUS IN COUNTRIES CONSIDERED TO HAVE HIGH LEVELS OF ANTIBIOTIC RESISTANCE COMPARED TO THOSE WITH LOW LEVELS
BMC InfectDis . 2014 Sep 22;14:513
A – Factor impacto JCR: 1,909 – Q2 – Pediatrics

• Martinón-Torres F.
IMMUNISATION AGAINST MENINGOCOCCUS B: THE CASE OF SPAIN
Lancet 2013 Nov 9; 382(9904):1552-3.
L – Factor Impacto JCR: 60,392 – D1 – Medicine, General & Internal

• J GomezCarballa; J Pardo Seco; L Fachal; A Vega; M Cebey; N Martinon Torres; F Martinón-Torres; A Salas.
INDIAN SIGNATURES IN THE MOST WESTERN EDGE OF THE EUROPEAN ROMANI DIASPORA: NEW INSIGHT FROM MITOGENOMES.
PLoSOne Oct 2013; 8(10):e75397
A – Factor Impacto JCR: 2,740 – Q2 – Multidisciplinary

• Martinón-Torres F, Montero-Martín M.
THE NEVER ENDING STORY OF CORTICOSTEROIDS IN ACUTE BRONCHIOLITIS
Pediatrics2013; 132:4 810-816
A – Factor Impacto JCR: 5,359 – Q1 Pediatrics

• Martinón-Torres F, Aramburo A, Martinón-Torres N, Cebey M, Seoane Pillado MT, MartinónSánchez JM.
A REVERSE EVIDENCE OF ROTAVIRUS VACCINES IMPACT
Hum VaccinImmunother. 2013 Jun; 9(6):1289-91.
A – Factor Impacto JCR: 2,619- Q2 – Immunology

• De Castro MJ, Illade L, Martinón-Torres F.
READ MY LIPS: ORAL MANIFESTATIONS OF SYSTEMIC DISEASES
Journal of Pediatrics 2013 Dic; 163 (6):1784-5.
A – Factor impacto JCR: 3,700 – Q1 – Pediatrics

• Pías-Peleteiro L, Cortés-Bordoy J, Martinón-Torres F.
DR. GOOGLE: WHAT ABOUT THE HUMAN PAPILLOMAVIRUS VACCINE?
Hum VaccinImmunother. 2013 Agos; 9(8): 1712-9
A – Factor Impacto JCR: 2,619- Q2 – Immunology

• Herberg JA, Kaforou M, Gormley S, Sumner ER, Patel E, Jones KDJ, Paulus S, Fink C, Martinón-Torres F, Montana G, Wright VJ, Levin M
TRANSCRIPTOMIC PROFILING IN CHILDHOOD H1N1/09 INFLUENZA REVEALS REDUCED EXPRESSION OF PROTEIN SYNTHESIS GENES
Journal of Infectious Diseases 2013 Nov 15; 208(10):1664-8.
A – Factor Impacto JCR: 5,022- Q1 – Immunology

• Rodgers ML, Esposito S, Principi N, Gutierrez-Brito M, Diez-Domingo, J, Pollard AJ, Snape M, Martinón-Torres F, Emini EA, Gruber WA, Patterson W, Gurtman A, Paradiso P, Scott DA, Thompson A.
IMMUNE RESPONSE TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE WITH A REDUCED DOSING SCHEDULE.
Vaccine 2013 Oct 1; 31(42):4765-74.
A – Factor Impacto JCR: 3,143 – Q2 – Immunology and Microbiology

• Diez-Domingo J, Gurtman A, Bernaola E, Giménez-Sánchez F, Martinón-Torres F, Pineda-Solas V, Delgado A, Infante-Marquez P, ,Liang HJ, Giardina PC, Gruber WC, Emini EA, Scott DA, on behalf of the 501 Study Group
EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AND CONCOMITANT MENINGOCOCCAL GROUP C CONJUGATE VACCINE IN HEALTHY INFANTS AND TODDLERS IN SPAIN
Vaccine 2013 Nov 4; 31(46):5486-94.
A – Factor Impacto JCR: 3,143 – Q2 – Immunology and Microbiology

• Martinón-Torres F, Giménez-Sánchez F, Gurtman A, Bernaola E, Diez-Domingo J, Carmona A, Sidhu M, Sarkozy DA, Gruber WC, Emini EA, Scott DA.
13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH MENINGOCOCCAL C TETANUS TOXOID CONJUGATE AND OTHER ROUTINE PEDIATRIC VACCINATIONS: IMMUNOGENICITY AND SAFETY.
Pediatr Infect Dis J. 2012 Apr; 31(4):392-9.
A – Factor Impacto JCR: 2,126– Q2 – Immunology

• Rüger G, Gabutti G, Rümke H, Rombo L, Bernaola E, Diez-Domingo J, Martinón-Torres F, Høgh B, Konstantopoulos A, Fiquet A, Thomas S, Eymin C, Baudin M.
SAFETY OF A TWO-DOSE REGIMEN OF A COMBINED MEASLES, MUMPS, RUBELLA AND VARICELLA LIVE VACCINE MANUFACTURED WITH RECOMBINANT HUMAN ALBUMIN
Pediatr Infect Dis J. 2012 Nov; 31(11):1166-72.
A – Factor Impacto JCR: 2,126– Q2- Immunology

• Ochoa Sangrador C, González de Dios J; Research Group of the aBREVIADo Project (Bronchiolitis–Study of Variability, Adequacy, and Adherence) (Martinón –Torres F).
MANAGEMENT OF ACUTE BRONCHIOLITIS IN EMERGENCY WARDS IN SPAIN: VARIABILITY AND APPROPIATENESS ANALYSIS (aBREVIADo Project).
Eur J Pediatr. 2012 Jul; 171(7):1109-19.
A – Factor Impacto JCR: 2,305 – Q2: Pediatrics

• Richmond P, Marshall H, Nissen M, Jiang Q, Kathrin U. Jansen, Garces-Sánchez M, Martinón-Torres F, Beeslaar J; Szenborn L; Wysocki L; Pérez JL, Eiden J, Harris S; Jones S.
SAFETY, IMMUNOGENICITY, AND TOLERABILITY OF MENINGOCOCCAL SEROGROUP B BIVALENT RECOMBINANT LIPOPROTEIN 2086 VACCINE IN HEALTHY ADOLESCENTS: A RANDOMISED, SINGLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 TRIAL
Lancet Infectious Diseases 2012 Aug; 12(8):597-607.
A – Factor impacto JCR: 24,446 – D1 – Immunology

• Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, Kieninger D, Prymula R, Dull P, Ypma E, Toneatto D, Kimura A, Pollard AJ; European MenB Vaccine Study Group (Martinón-Torres F).
IMMUNOGENICITY AND TOLERABILITY OF RECOMBINANT SEROGROUP B MENINGOCOCCAL VACCINE ADMINISTERED WITH OR WITHOUT ROUTINE INFANT VACCINATIONS ACCORDING TO DIFFERENT IMMUNIZATION SCHEDULES: A RANDOMIZED CONTROLLED TRIAL.
JAMA. 2012 Feb 8; 307(6):573-82.
A – Factor impacto JCR: 45,540 – D1 – Pediatrics

• Martinón-Torres F, Martinón-Torres N, Bouzón-Alejandro M, Redondo Collazo L, Pértega-Díaz S, Seoane-Pillado MT, Aboal-Viñas J, San-Martín M.
ACUTE GASTROENTERITIS HOSPITALIZATIONS AMONG CHILDREN AGED <5 YEARS BEFORE AND AFTER INTRODUCTION OF ROTAVIRUS VACCINES: A HOSPITAL-BASED SURVEILLANCE STUDY IN GALICIA, SPAIN
Hum VaccinImmunother 2012 Jul; 8(7):946-52
A – Factor Impacto JCR: 2,619- Q2 – Immunology

• Farias JA, Fernández A, Monteverde E, Flores JC, Baltodano A, Menchaca A, Poterala R, Pánico F, Johnson M, vonDessauer B, Donoso A, Zavala I, Zavala C, Troster E, Peña Y, Flamenco C, Almeida H, Nilda V, Esteban A; Latin-American GroupforMechanicalVentilation in Children (Martinón-Torres F).
MECHANICAL VENTILATION IN PEDIATRIC INTENSIVE CARE UNITS DURING THE SEASON FOR ACUTE LOWER RESPIRATORY INFECTION.A MULTICENTER STUDY.
Pediatr Crit Care Med. 2012; 13(2): 158-64
A – Factor impacto JCR: 2,854 – Q1- Pediatrics

• Martinón-Torres F.
NONINVASIVE VENTILATION WITH HELIUM-OXYGEN IN CHILDREN.
J Crit Care 2012 Apr; 27(2):220.e1-9
A – Factor impacto JCR: 2,685– Q3 Critical care Medicine

• Martinón-Torres F, Dosil-Gallardo S, Pérez Del Molino-Bernal ML, Sánchez FP, Tarrago D, Alvez F, Diaz SP, Martinón-Torres N, Martinón Sánchez JM.
PLEURAL ANTIGEN ASSAY IN THE DIAGNOSIS OF PEDIATRIC PNEUMOCOCCAL EMPYEMA.
J Crit Care 2012 Jun; 27(3):321.e1-4
A – Factor impacto JCR: 2,685 – Q3 – Critical Care Medicine

• Farias JA, Fernández A, Monteverde E, Flores JC, Baltodano A, Menchaca A, Poterala R, Pánico F, Johnson M, vonDessauer B, Donoso A, Zavala I, Zavala C, Troster E, Peña Y, Flamenco C, Almeida H, Nilda V, Esteban A; Latin-American GroupforMechanicalVentilation in Children (Martinón-Torres F).
MECHANICAL VENTILATION IN PEDIATRIC INTENSIVE CARE UNITS DURING THE SEASON FOR ACUTE LOWER RESPIRATORY INFECTION.A MULTICENTER STUDY.
Pediatr Crit Care Med. 2011; 12(5): 1-7.
A – Factor impacto JCR: 2,854 – Q1 – Pediatrics

• Bouzón-Alejandro M, Redondo-Collazo L, Sánchez-Lastres JM, Martinón-Torres N, Martinón-Sánchez JM, Martinón-Torres F; ROTACOST researchteam.
PROSPECTIVE EVALUATION OF INDIRECT COSTS DUE TO ACUTE ROTAVIRUS GASTROENTERITIS IN SPAIN: THE ROTACOST STUDY.
BMC Pediatr. 2011 Sep 14; 11:81.
A – Factor impacto JCR: 1,909 – Q2 – Pediatrics

• Bouzón Alejandro M, Diez Domingo J, Martinón-Torres F.
CIRCOVIRUS AND IMPACT OF TEMPORARY WITHDRAWAL OF ROTAVIRUS VACCINES IN SPAIN.
Hum Vaccin. 2011 Jul; 7(7):798-9.
A – Factor Impacto JCR: 2,619– Q2 – Immunology

• Cortés J, Martinón-Torres F, Ramón y Cajal JM, Ferret G, Gil A.
CONSIDERATIONS ON THE CLINICAL APPLICATION OF THE HUMAN PAPILLOMAVIRUS VACCINE IN SPAIN.
Hum Vaccin. 2011 May; 7(5):585-9.
A – Factor Impacto JCR: 2,619– Q2 – Immunology

• Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, Sánchez Lastres JM, Pértega Díaz S, Seoane Pillado MT, Martinón Sánchez JM; ROTACOST researchteam.
EFFECTIVENESS OF ROTAVIRUS VACCINATION IN SPAIN.
Hum Vaccin. 2011 Jul; 7(7):757-61.
A – Factor Impacto JCR: 2,619– Q2 – Immunology

• Rodríguez-Tenreiro, Carmen; Martinón-Torres, F
VACUNA UNIVERSAL FRENTE A MENINGOCOCO B
AnPediatrContin. 2011; 9(1): 60-3

• Giménez-Sánchez F, Kieninger DM, Kueper K, Martinón-Torres F, Bernaola E, Díez-Domingo J, Steul K, Juergens C, Gurtman A, Giardina P, Liang JZ, Gruber WC, Emini EA, Scott DA; 501 and 006 study groups.
IMMUNOGENICITY OF A COMBINATION VACCINE CONTAINING DIPHTHERIA TOXOID, TETANUS TOXOID, THREE-COMPONENT ACELLULAR PERTUSSIS, HEPATITIS B, INACTIVATED POLIO VIRUS, AND HAEMOPHILUS INFLUENZAE TYPE B WHEN GIVEN CONCOMITANTLY WITH 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE.
Vaccine. 2011 Aug 11; 29(35):6042-8.
A – Factor Impacto JCR: 3,143 – Q2 – Immunology and Microbiology

• Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators (Martinón-Torres F).
CANDIDA BLOODSTREAM INFECTIONS IN INTENSIVE CARE UNITS: ANALYSIS OF THE EXTENDED PREVALENCE OF INFECTION IN INTENSIVE CARE UNIT STUDY.
Crit Care Med. 2011 Apr; 39(4):665-70.
A – Factor impacto JCR: 7,414- Q1 – Critical Care Medicine

• Davila S, Wright VJ, Khor CC, Lim KS, Binder A, Breunis WB, Inwald D, Nadel S, Betts H, Carrol E, de Groot R, Hazelzet J, Emonts M, Lim CC, Kuijpers TW, Martinón-Torres F, Salas A, Zenz W, Levin M, Hibberd ML, on behalf of the ESPID meningococcal genetics consortium.
GENOME-WIDE ASSOCIATION STUDY IDENTIFIES VARIANTS IN THE CFH REGION ASSOCIATED WITH HOST SUSCEPTIBILITY TO MENINGOCOCCAL DISEASE
Nature Genetics 2010 Sep; 42(9):772-6.
A – Factor impacto JCR: 27,603 – D1 –Genetics & Heredity

• Santschi M, Jouvet P, Leclerc F, Gauvin F, Newth CJ, Carroll CL, Flori H, Tasker RC, Rimensberger PC, Randolph AG; for the PALIVE Investigators, the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI); the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) (Martinón-Torres F).
ACUTE LUNG INJURY IN CHILDREN: THERAPEUTIC PRACTICE AND FEASIBILITY OF INTERNATIONAL CLINICAL TRIALS
Pediatr Crit Care Med 2010 Nov; 11(6):681-9
Factor impacto JCR: 2,854- Q1 – Pediatrics

• Giménez F, Delgado A, Martinón-Torres F, Bernaola E, The Rotavirus Research Group of The Pediatric Spanish Association
MULTICENTER PROSPECTIVE STUDY ANALYSING THE ROLE OF ROTAVIRUS ON ACUTE GASTROENTERITIS IN SPAIN
Acta Paediatrica 2010 May; 99(5):738-742.
A – Factor impacto JCR: 2,111 – Q2 – Pediatrics

• Gonzalez de Dios J, Ochoa Sangrador C y Grupo Investigador del Proyecto aBREVIADo (F.Martinón-Torres)
ESTUDIO DE VARIABILIDAD EN EL ABORDAJE DE LA BRONQUIOLITIS AGUDA EN ESPAÑA EN RELACIÓN CON LA EDAD DE LOS PACIENTES
Anales de Pediatría (Barc) 2010; 72(1): 4-18
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F., Peña Guintian J.
¿SE PODRÍAN MINIMIZAR LOS EFECTOS DE LA PANDEMIA POR GRIPE A (H1N1) EN ESPAÑA CON LA VACUNA ANTINEUMOCÓCICA CONJUGADA?
Arch Bronconeumol. 2010; 46(6): 335-6
A – Factor impacto JCR: 4,957 – Q1 – Respiratory System

• GamellFullà A, Corniero Alonso P, Parra Cotanda C, Trenchs Sainz de la Maza V, Luaces Cubells C, Grupo Calidad SEIP (F. Martinón Torres)
¿ESTÁN PRESENTES LOS PADRES DURANTE LOS PROCEDIMIENTOS INVASIVOS? ESTUDIO EN 32 HOSPITALES DE ESPAÑA
Anales de Pediatría (Barc) 2010; 72(4): 243-9
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• González de Dios J, Ochoa Sangrador C; Grupo de revisión y panel de expertos de la Conferencia de Consenso del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad y ADecuación).(Andrés de Llano JM, Aparicio Rodrigo M, Bajo Delgado AF, Balaguer A, Bonillo Perales A, Buñuel Alvarez JC, Canut Blasco A, Eiros Bouza JM, Fàbrega Sabaté J, Fernández Alonso JE, Fernández Rodríguez M, Lapeña López de Armentia S, López Avila J, Molinos Norniella C, Orejón de Luna G, Todorcevic S, García-Puente Sánchez M, Muñoz Martín B, Callén Blecua MT, Carbonell Estrany X, García de la Rubia S, García Marcos L, Gutiérrez Larraya F, Korta Murua J, Luaces Cubells C, Martinón Torres F, Praena Crespo M, Rodríguez Fernández R, Sánchez-Etxaniz J.)
CONFERENCIA DE CONSENSO SOBRE BRONQUIOLITIS AGUDA (I): METODOLOGÍA Y RECOMENDACIONES
Anales de Pediatría (Barc) 2010; 72(3):221.e1-221.e33
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Cortés-Bordoy J, Martinón-Torres F.
THE SPANISH HUMAN PAPILLOMAVIRUS VACCINE CONSENSUS GROUP: A WORKING MODEL
Human Vaccine 2010 Agos; 6(8): 635-9
A – Factor Impacto JCR: 2,619 Q2 biotechnology & applied microbiology

• Martinón-Torres F, Peña Guitian J.
¿SE PODRÍAN MINIMIZAR LOS EFECTOS DE LA PANDEMIA POR GRIPE A (H1N1) EN ESPAÑA CON LA VACUNA ANTINEUMOCÓCICA CONJUGADA?
ArchBronconeumol. 2010 Jun; 46(6):335-6.
A – Factor de Impacto JCR: 4,957- Q1- RespiratorySystem

• Salas A, Fachal L, Marcos Alonso S, Vega A, Martinón-Torres F, Grupo de investigación ESIGEM (Estudio sobre la influencia Genética en la Enfermedad meningocócica)
INVESTIGATING THE ROLE OF MITOCHONDRIAL HAPLOGROUPS IN GENETIC PREDISPOSITION TO MENINGOCOCCAL DISEASE
PLoS ONE 2009; 4(12): e8347.
A – Factor impacto JCR: 2,740 – Q2- Multidisciplinary

• Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K; EPIC II Group of Investigators (Martinón-Torres F).
INTERNATIONAL STUDY OF THE PREVALENCE AND OUTCOMES OF INFECTION IN INTENSIVE CARE UNITS.
JAMA 2009 Dec 2; 302(21):2323-9
A – Factor impacto JCR: 45,540 – D1 – Pediatrics

• Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez-Campderá A, Martinón-Torres F, Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
CALENDARIO VACUNAL DE LA ASOCIACION ESPAÑOLA DE PEDIATRÍA: RECOMENDACIONES 2009
Anales de Pediatría (Barc) 2009; 70(1):72-82
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón Torres F, Medina Villanueva A, Pons Odena M.
PROTOCOLO DE VENTILACIÓN NO INVASIVA NEONATAL: CUIDADO CON RECOMENDAR PRESIONES DEMASIADO BAJAS
AnPediatr (Barc) 2008 Dic; 69(6):577-8
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Giménez Sánchez F, Delgado Rubio A, Martinón Torres F, Asensi Botet F, Miranda Valdivieso M, Gómez Llorente JL, Alfayate Miguélez S, Carmona Martínez A, Romero González J, Crespo Hernández M, Baca Cots M, onbehalfof Grupo ROTASCORE.
IMPACTO FAMILIAR DE LA GASTROENTERITIS POR ROTAVIRUS EN MENORES DE DOS AÑOS
AnPediatr (Barc) 2008 Dic; 69(6):515-20
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, DosilGallardo S, Pérez Gay L, Alvez F, Rodríguez A, Martinón Sánchez JM
HAS THE NUMBER OF CASES OF PEDIATRIC EMPYEMA INCREASED IN NORTH-WEST SPAIN?
Pediatric Infectious Disease Journal 2008; 3(3):175-179
A – Factor Impacto JCR: 2,126– Q2 – Immunology

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM
NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE WITH HELIOX VERSUS AIR-OXYGEN IN INFANTS WITH ACUTE BRONCHIOLITIS: A CROSSOVER STUDY
Pediatrics. 2008 May; 121(5):e1190-5
A – Factor impacto JCR: 5,359 – Q1 – Pediatrics

• Martinón-Torres F
EL PEDIATRA ES UNA DE LAS CLAVES EN LA ERRADICACIÓN DEL CÁNCER DE CUELLO DE ÚTERO
Medicina Clínica (Barc) 2008; 130(12):478-9.
L – Factor impacto JCR: 1,635 – Q3 – Medicine General &Internal

• Martinón-Torres F, Bouzón-Alejandro M, López Sousa M, Redondo Collazo L, Almeida Agudín S, Astrogano Fernández C, Martinón-Sánchez JM.
AN ESTIMATION OF INDIRECT COSTS CAUSED BY ACUTE ROTAVIRUS GASTROENTERITIS IN A GALICIAN AREA, SPAIN
Eur J Pediatr 2008; 167(3): 337-9
A – Factor Impacto JCR: 2,305- Q2- Pediatrics

• Rodríguez Núñez A, Igeño Cano JC, DosilGallardo S, Rivas Pumar P, Martinón Torres F.
¿DEBEN LOS NIÑOS PARTICIPAR EN COMPETICIONES DE MOTOCROSS?
AnPediatr (Barc) 2008 Sep; 69(3):279-81
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón Torres F.
ACTUALIZACIÓN DE LA VACUNACIÓN FRENTE AL VPH
Acta Paediatrica 2008; suppl: 2-11
A – Factor de Impacto JCR: 2,111 – Q2 – Pediatrics

• Luaces Cubells C, Ortiz Rodríguez J, Trenchs Sainz de la Maza V, Pou Fernández J, y Grupo De Trabajo De Calidad De La Sociedad Española De Urgencias De Pediatría (SEUP) (Martinón-Torres F)
ENCUESTA NACIONAL SOBRE LAS URGENCIAS PEDIATRICAS. ASPECTOS ORGANIZATIVOS Y FUNCIONALES
Emergencias 2008; 20:322-327.
A – Factor Impacto JCR: 3,173 Q1 Emergency Medicine

• Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez-Campderá A, Martinón-Torres F, Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
CALENDARIO VACUNAL DE LA ASOCIACION ESPAÑOLA DE PEDIATRÍA: RECOMENDACIONES 2008
Anales de Pediatría (Barc) 2008; 68(1):63-9
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez-Campderá A, Martinón-Torres F, Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
CRITERIOS DE INCLUSIÓN EN EL CALENDARIO VACUNAL DE LA ASOCIACIÓN ESPAÑOLA DE PEDIATRÍA
AnPediatr (Barc) 2008; 68(1):58-62.
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez-Campderá A, Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
¿POR QUÉ HAY MAS EMPIEMAS PEDIÁTRICOS EN ESPAÑA?
AnPediatr (Barc) 2008; 68(2):158-64.
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• López Sousa M, Bouzón Alejandro A, Martinón Torres F
ROTAVIRUS Y SUS COSTES INDIRECTOS
AnPediatr (Barc) 2008; 69(1): 89
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez-Campderá A, Martinón-Torres F, Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
CALENDARIO DE VACUNACIÓN DE LA ASOCIACIÓN ESPAÑOLA DE PEDIATRÍA: RECOMENDACIONES 2007
Anales de Pediatría (Barc) 2007; 66(1):62-9
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Castelló Muñoz A, Carreira Sande N, Bouzón Alejandro M, Pérez Valle S, Rodríguez Núñez A, Martinón Sánchez JM, Martinón-Torres F
UTILIDAD DEL HELIOX EN EL MANEJO DE UNA OBSTRUCCIÓN GRAVE DE LA VÍA AÉREA POR UN HEMANGIOMA SUBGLÓTICO
Anales de Pediatría (Barc) 2007; 67(1): 61-4
L – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Rivas Pumar PM, RodríguezNúñez A, Blanco-Ons Fernández P, Sánchez Santos L, Redondo Collazo L, Martinón-Torres F, Martinón Sánchez JM.
CONSECUENCIAS A LARGO PLAZO DE LOS TRAUMATISMOS PEDIÁTRICOS QUE PRECISARON CUIDADOS INTENSIVOS
Anales de Pediatría (Barc) 2007; 66(1):4-10
L – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Giménez Sánchez F, Martinón-Torres F, Bernaola Iturbe E, Baca Cots M, de Juan Martín F, Díez Delgado J, Garcés Sánchez M, Gómez-Campderá A , Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
DOS VACUNAS FRENTE A ROTAVIRUS SEGURAS Y EFICACES
Anales de Pediatría (Barc) 2007; 66(2):191-200.
L – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Baca M, Pérez L, Martinón-Torres F.
VACUNA DEL TÉTANOS
AnPediatrContin 2007; 5(4):230-4.

• Gómez-Lado C, Martinón-Torres F, Álvarez-Moreno A, Eiris-Puñal J, Carreira-Sande N, RodríguezNúñez A, Castro-Gago A.
LEUCOENCEFALOPATÍA POSTERIOR REVERSIBLE: UNA COMPLICACIÓN INFRECUENTE EN EL CURSO DEL SÍNDROME HEMOLÍTICO URÉMICO
Rev Neurol 2007; 44(8):475-8
L – Factor impacto JCR: 0,562 – Q4 – Clinical Neurology

• López YM, Pilar FJ, Medina JA, López-Herce J, Pons M, Balcells J, Martinón-Torres F, Modesto M, García JA.
COURSES ON MECHANICAL VENTILATION IN PEDIATRICS: FIRST EXPERIENCE IN SPAIN
PediatrPulmonol 2007; 42(11):1072-7
A – Factor impacto: 2,534 – Q2 – Pediatrics

• Rodríguez-Nuñez A, López-Herce J, Gil-Anton J, Hernandez A, Rey C; the RETSPED Working Group of the Spanish Society of Pediatric Intensive Care.
RESCUE TREATMENT WITH TERLIPRESSIN IN CHILDREN WITH REFRACTORY SEPTIC SHOCK: A CLINICAL STUDY.
Crit Care . 2006 Feb; 10(1):R20
A – Factor impacto JCR: 6,407 – Q1 – Critical Care Medicine

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE WITH HELIOX IN INFANTS WITH ACUTE BRONCHIOLITIS
Respiratory Medicine 2006 Aug;100(8):1458-62
A – Factor impacto JCR: 3,095 – Q2 – Respiratory System

• Martinón-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez-Campderá A, Picazo JJ, Pineda Solás V
VACUNA FRENTE AL VIRUS DEL PAPILOMA HUMANO: UN NUEVO RETO PARA EL PEDIATRA
AnPediatr (Barc). 2006 Nov; 65(5):461-9
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, Garcés Sánchez M, Gómez-Campderá A, Martinón-Torres F, Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
CALENDARIO DE VACUNACIÓN DE LA ASOCIACION ESPAÑOLA DE PEDIATRÍA: RECOMENDACIONES 2006
Anales de Pediatría (Barc) 2006; 64(1):74-7
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Blanco-Ons Fernández P, Sánchez Santos L, Domínguez Pérez M, Martinón Torres F, y RodríguezNúñez A.
NIÑOS Y MOTOS. ¿PODEMOS HACER ALGO MÁS PARA PREVENIR LOS ACCIDENTES?
Anales de Pediatría (Barc) 2006; 64(2):174-5
L – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Carreira Sande N, Martínez Bugarín R, Meijide Del Río F, Martinón-Torres F, Rodríguez Núñez A.
APLICACIÓN PRECOZ DE LA VENTILACIÓN DE ALTA FRECUENCIA OSCILATORIA EN UN LACTANTE CON NEUMOPATÍA QUÍMICA GRAVE
Anales de Pediatría (Barc) 2006; 65(1):84-5.
L – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Giménez Sánchez F, Martinón-Torres F, Bernaola Iturbe E, Baca Cots M, de Juan Martín F, Díez Delgado J, Garcés Sánchez M, Gómez-Campderá A, , Picazo JJ, Pineda Solás V. Comité Asesor Vacunal de la Asociación Española de Pediatría
EL PAPEL DE LA VACUNA FRENTE A ROTAVIRUS EN LOS CALENDARIOS DE VACUNACIÓN INFANTIL
Anales de Pediatría (Barc) 2006; 64(6):573-7.
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Pineda Solas A, Bernaola Iturbe E, Martinón-Torres F, Baca Cots M, De Juan Martin F, Gómez Campdera JA, Diaz Domingo J, Garces Sánchez M, GiménezSánchez F, Picazo J. Comité Asesor Vacunal de la Asociación Española de Pediatría
RECOMENDACIONES DEL COMITÉ ASESOR DE VACUNAS DE LA ASOCIACIÓN ESPAÑOLA DE PEDIATRÍA: VACUNACIÓN ANTIGRIPAL CAMPAÑA 2006-2007
Anales de Pediatría (Barc) 2006 Sep; 65(3):252-5.
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F, Crespo Suárez PA, Silvia Barbàra C, Castelló Muñoz A, Rodríguez Núñez A, Martinón Sánchez JM.
VENTILACIÓN NO INVASIVA CON HELIOX EN UN LACTANTE CON SÍNDROME DE DIFICULTAD RESPIRATORIA AGUDA
Anales de Pediatría (Barc) 2005; 62(1):64-7.
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F, Martinón Sánchez JM.
¿HAY EVIDENCIAS CIENTIFICAS QUE JUSTIFIQUEN EL USO DE BRONCODILATADORES EN LACTANTES CON BRONQUIOLITIS AGUDA?
Anales de Pediatría Continuada 2005; 3(1):44-8
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• López Franco M, Rodríguez Núñez A, Fernández Sanmartín M, Marcos Alonso S, Martinón-Torres F, Martinón Sánchez JM.
SÍNDROME DE DESGASTE PROFESIONAL EN EL PERSONAL ASISTENCIAL PEDIÁTRICO
Anales de Pediatría (Barc) 2005; 62(3):248-51.
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Marcos Alonso S, MoliniMenchón N, RodríguezNúñez A, Martinón-Torres F, Martinón Sánchez JM:
TRAQUEITIS BACTERIANA: UNA CAUSA INFECCIOSA DE OBSTRUCCIÓN DE LA VÍA AÉREA QUE HAY QUE CONSIDERAR EN LA INFANCIA
Anales de Pediatría (Barc) 2005; 63(2):164-8.
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Silvia Bárbara C, RodríguezNúñez A, López Franco M, Martinón-Torres F, Martinón Sánchez JM.
TRAQUEOSTOMÍA PERCUTÁNEA BAJO CONTROL ENDOSCÓPICO EN ADOLESCENTES.
Anales de Pediatría (Barc) 2005; 63(2):160-3
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Eirís Puñal J, Rodríguez Núñez A, Gómez Lado C, Martinón-Torres F,Castro-Gagoa M, Martinón Sánchez JM
SÍNCOPE EN EL ADOLESCENTE. ORIENTACIÓN DIAGNÓSTICA Y TERAPÉUTICA
AnPediatr (Barc) 2005; 63(4):330-9
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F, Dargallo Carbonell T, Marcos Alonso S, Cabanas Rodríguez P, González Alonso N, Almeida Agudín S.
INGESTIÓN DE CUERPOS EXTRAÑOS DE PLOMO
Anales de Pediatría (Barc) 2005; 63(5):453-6
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• A. Medina, M. Pons, J. López-Herce, F. Martinón-Torres y grupo de Respiratorio de la SEIP
CURSOS DE VENTILACIÓN MECÁNICA PEDIÁTRICA Y NEONATAL
Anales de Pediatría (Barc) 2005; 62(5): 491-517
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Rivas Pumar P, Mósquera Agrelo MC, Redondo Collazo L, Martinón-Torres F, Rodríguez Núñez A
LAS CONSECUENCIAS DE LOS TRAUMATISMOS PEDIÁTRICOS. REPERCUSIÓN A LARGO PLAZO EN CUANTO A SITUACIÓN FUNCIONAL Y GRADO DE ADAPTACIÓN SOCIAL
AnPediatr (Barc) 2005; 62 (Supl 2): 1-263
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F, Crespo Suárez P.A, Silvia Barbàra C, Castelló Múñoz A, Rodríguez Núñez A. y Martinón Sánchez J.M
VENTILACIÓN NO INVASIVA CON HELIOX EN UN LACTANTE CON SÍNDROME DE DIFICULTAD RESPIRATORIA AGUDA
AnPediatr (Barc) 2005; 62 (1): 64-7
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Hernández Bejarano MJ, Castello Muñoz A, Martinón-Torres F, Martinón-Sánchez JM, Rodríguez-Núñez A
UTILIDAD DEL ÓXIDO NITROSO COMO COADYUVANTE EN LA ANALGOSEDACIÓN DE NIÑOS
AnPediatr (Barc) 2005; 62 (Supl 2): 1-263
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Castelló Múñoz A, Barbára SC, Lojo Rodríguez M, Martinón-Torres F
TROMBOFILIA INDUCIDA POR LA VARICELA
AnPediatr (Barc) 2005; 62 (Supl 2): 1-263
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Fernández Sanmartín M, Cabanas Rodríguez P, Granero Asencio M, Saavedra Chaves E, Martínez Pérez L, Berdullas Rodríguez MI, Otero Ferreiro MJ, Martinón-Torres F, RodríguezNúñez A.
CAMBIO DE ACTITUDES RESPECTO AL USO DE CASCO EN BICICLETA DESPUÉS DE SUFRIR UN ACCIDENTE GRAVE
Anales de Pediatría (Barc) 2004; 60(2):189-90.
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Rubio Álvarez J, Sierra Quiroga J, Rubio Taboada C, Fernández González A, Martinón-Torres F, García Bengochea J.
CARDIAC ASPERGILLOSIS WITH PEDUNCULATED MASS IN THE LEFT VENTRICLE
Tex Heart Inst J 2004; 31(4):439-41.
A – Factor impacto JCR: 1,023– Q4 Cardiac & Cardiovascular Systems

• Martinón-Torres F
RENOVACIÓN GENERACIONAL
Anales de Pediatría (Barc) 2004; 60(supl4):137-140.
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F, Crespo Súarez PA, MoliníMenchón N, Fernández Sanmartín M, Rodríguez Núñez A, Iglesias Meleiro JM, Redondo Collazo L
VENTILACIÓN NO INVASIVA CON HELIOX APLICADA A LACTANTES
AnPediatr 2004; 60 (Supl 3): 1-225
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F, MoliníMenchón N, Crespo Suárez PA, Iglesias Meleiro JM, Rodríguez Núñez A, Fernández Sanmartín M, Redondo Collazo L
VENTILACIÓN NO INVASIVA CON HELIOX EN EL TRATAMIENTO DE LA BRONQUIOLITIS AGUDA SEVERA
AnPediatr 2004; 60 (Supl 3): 1-225
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Fernández Sanmartín M, Rodríguez Núñez A, Martinón-Torres F, González Alonso N, Iglesias Meleiro JM, Crespo Suárez PA, Martinón Sánchez JM
TERLIPRESINA EN EL TRATAMIENTO DEL SHOCK SÉPTICO REFRACTARIO A CATECOLAMINAS
AnPediatr 2004; 60 (Supl 3): 1-225
A – Factor impacto JCR: 1,313 – Q3 Pediatrics

• Rodríguez Núñez A, Crespo Suárez P, Martins de Oliveira Pereira Caldas C, Pérez Rodríguez MT, Martinón-Torres F, Martinón Sánchez JM.
INFORMACION Y ATENCIÓN EN CUIDADOS INTENSIVOS PEDIÁTRICOS. OPINIONES DE LOS PADRES.
Anales de Pediatría (Barc) 2004; 61(3):231-5.
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Martinón-Torres F, Iglesias Meleiro JM, Fernández Sanmartín M, RodríguezNúñez A, Martinón Sánchez JM.
PROTEINA C ACTIVADA HUMANA RECOMBINANTE EN EL TRATAMIENTO DE NIÑOS CON PURPURA FULMINANTE MENINGOCÓCICA.
Anales de Pediatría (Barc) 2004; 61(3):261-5.
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• RodríguezNúñez A, Perea Rodríguez ME, Martinón-Torres F.
¿RESPETAMOS LOS DERECHOS DEL NIÑO?
Anales de Pediatría (Barc) 2004; 61(5):443-4.
A – Factor Impacto JCR: 1,313 – Q3 Pediatrics

• Rodríguez-Núñez A, Fernández-Sanamartín M, Martinón-Torres F, González-Alonso N, Martinón-Sánchez JM.
TERLIPRESSIN FOR CATECHOLAMINE-RESISTANT SEPTIC SHOCKIN CHILDREN
Intensive Care Med 2004; 30:477-80.
A – Factor impacto JCR: 17,679 – D1 – Critical Care Medicine

• Martinón-Torres F
CURRENT TREATMENT FOR ACUTE VIRAL BRONCHIOLITIS IN INFANTS
Expert Opinion on Pharmacotherapy 2003; 4(8):1355-71.
A – Factor impacto JCR: 2,878 –Q2 – Pharmacology and Pharmacy

• Martinón-Torres F, Martinón Sánchez JM.
TORACOCENTESIS Y DRENAJE PLEURAL
Anales de Pediatría Continuada 2003; 1(3):159-65.
A – Factor impacto JCR: 1,313 – Q3 – Pediatrics

• Castro-Gago M, Rodríguez-Núñez A, Eíris Puñal J, Martinón-Torres F, Martinón-Sánchez JM
LE SYNDROME POSTURAL DE TACHYCARDIE ORTHOSTATIQUE EN PÉDIATRIE. ÉVALUACION AVEC UN TILT-TEST MULTI-PARAMÉTRIQUE
Rev Neurol (Paris), 2003, 159(12): 1186-1197
A – Factor impacto JCR: 0,562 – Q4 – Clinical Neurology

• Martinón-Torres F, Ibarra de la Rosa I, Fernández Sanmartín M, García Menor E, Martinón Sánchez JM.
VENTILACION DE ALTA FRECUENCIA
Anales de Pediatría (Barc) 2003; 59(2):155-80.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Fernández Sanmartín M, Saavedra Chaves E, Granero Asencio M, Martinón Sánchez JM.
AGUDIZACIÓN GRAVE DEL ASMA
Anales de Pediatría (Barc) 2003; 58 (supl1):1-13.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Rodríguez Núñez A, Martinón-Torres F, Martinón Sánchez JM.
GASES MEDICINALES: OXIGENO Y HELIO
Anales de Pediatría 2003; 59(1):74-79
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Rodríguez Núñez A, Martinón-Torres F, Martinón Sánchez JM.
VENTILACION MECANICA EN LA BRONQUIOLITIS”
Anales de Pediatría (Barc) 2003; 59(4):363-6.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Fernández Sanmartín M, Rodríguez Núñez A, Martinón-Torres F, Eiris Puñal J, Martinón Sánchez JM.
SÍNCOPE CONVULSIVO: CARACTERISTICAS Y REPRODUCIBILIDAD MEDIANTE EL TEST DE LA CAMA BASCULANTE
Anales de Pediatría (Barc) 2003; 59(5):441-7.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón Sánchez J, Martínez Soto S, Martinón-Torres F, MartinónSánchezF.
SINTOMATOLOGÍA DE LA VARICELA
Anales de Pediatría (Barc) 2003; 59(supl1):14-7.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
HELIOX QUESTIONS
Pediatrics 2003; 111(2):441-3; author reply 441-3
A – Factor impacto JCR: 5,359 – Q1 – Pediatrics

• Martinón-Torres F, Rodríguez Núñez A, Martinón Sánchez JM.
HELIOX THERAPY
Pediatrics 2002; 110 (4): 847
A – Factor impacto JCR: 5,359 – Q1 – Pediatrics

• Martinón-Torres F, Rodríguez Núñez A, Martinón Sánchez JM.
MORE ABOUT HELIOX AND BRONCHIOLITIS
Pediatrics 2002; 110 (1): 198
A – Factor impacto JCR: 5,359 – Q1 – Pediatrics

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
BRONQUIOLITIS Y ADRENALINA: REVISANDO LAS EVIDENCIAS
Anales de Pediatría 2002; 56(4):363-4.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Pérez Muñuzuri A, Fuster Siebert M, Bravo Mata M, Martinón-Torres F, Porto Arceo J, Monasterio Corral L.
SÍNDROME POSPERICARDIOTOMIA: RECURRENCIAS TARDÍAS
Anales de Pediatría 2002; 56(4):369-70.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Rodríguez Núñez A, Martinón-Sánchez JM
TRATAMIENTO CON HELIOX EN LACTANTES AFECTADOS DE BRONQUITIS AGUDA
Pediatrics 2002; 53 (1): 20-25
A – Factor impacto JCR: 5,359 – Q1 – Pediatrics

• Martinón-Torres F, Fernández Sanmartín M, Martinón Sánchez JM.
¿SON NECESARIAS MAS EVIDENCIAS PARA APLICAR LA VENTILACION DE ALTA FRECUENCIA OSCILATORIA?
Anales de Pediatría (Barc) 2002; 57(1):70-1.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F
HIGH-FREQUENCY OSCILLATORY VENTILATION: “PLEASE, KEEP YOUR EYES ON ME”, SAID THE PATIENT.
Pediatrics 2002; 109 (3):554-5.
A – Factor impacto JCR: 5,359 – Q1 – Pediatrics

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
HELIOX THERAPY IN INFANTS WITH ACUTE BRONCHIOLITIS
Pediatrics 2002; 109(1):68-73.
A – Factor impacto JCR: 5,359 – Q1 – Pediatrics

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
ADVANCES IN MECHANICAL VENTILATION
New England Journal of Medicine, 2001; 345(15):1133-4.
A- Factor de impacto JCR: 74,699 Q1- D1 Medicine, General &Internal

• Martinón-Torres F, RodríguezNúñez A, Fernández Cebrian S, Eiris Puñal J, Pérez Muñuzuri A, Martinón Sánchez JM.
THE RELATION BETWEEN HYPERVENTILATION AND PEDIATRIC SYNCOPE
Journal of Pediatrics 2001; 138(6):894-7.
A – Factor impacto JCR: 3,700 – Q1 – Pediatrics

• Martinón Sánchez JM, Martinón-Torres F, RodríguezNúñez A, Martínez Soto MI, Rial Lobaton C, Jaimovich DG.
VISION PEDIATRICA DEL TRANSPORTE MEDICALIZADO
Anales Españoles de Pediatría 2001; 54(3): 260-6.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Pérez Muñuzuri A, Fernández Cebrián S
RETRASO DEL CRECIMIENTO INTRAUTERINO Y POLIMALFORMACIONES
Anales Españoles de Pediatría 2001; 54(2): 189-90.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
UTILIDAD DE LA CAPNOGRAFÍA EN EL PACIENTE CRITICO CON VENTILACION MECANICA
Medicina intensiva 2001; 25(3)
A – Factor impacto JCR: 2,363- Q3 – Critical Care Medicine

• Martinón-Torres F, Rodríguez Núñez, Martinón Sánchez JM.
EVIDENCIAS EN EL TRATAMIENTO DE LA BRONQUIOLITIS
Anales Españoles de Pediatría 2001; 54:378-83.
A – Factor Impacto JCR: 1,313 – Q3- Pediatrics

• Rodríguez Núñez A, Eirís Puñal J, Martinón-Torres F, Martinón Sánchez JM.
CODIFICACION DIAGNOSTICA DEL SÍNCOPE EN URGENCIAS DE PEDIATRIA
Anales Españoles de Pediatría 2001; 54(4): 415-6.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Rodríguez Núñez A, Martinón-Torres F, Martinón Sánchez JM.
QUIMIOPROFILAXIS DE LA ENFERMEDAD MENINGOCOCICA CON AZITROMICINA Y CIPROFLOXACINO
Anales Españoles de Pediatría 2001; 54(5):525-6.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, RodríguezNúñez A, Martinón Sánchez JM.
BRONQUIOLITIS AGUDA: EVALUACION DEL TRATAMIENTO BASADA EN LA EVIDENCIA
Anales Españoles de Pediatría 2001; 55(4):345-54.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• RodríguezNúñez A, Martinón-Torres F, Eiris J.
SYNCOPE AND SEIZURES: IT´S TIME FOR EVIDENCE!
Journal of Child Neurology 2000; 15(9): 634
A – Factor impacto JCR: 2,713 – Q3 Pediatrics

• Martinón-Torres F, Martinón-Sánchez JM, Martinón-Sánchez F.
CLITORIS AND LABIA MINORA AGENESIS: AN UNDESCRIBED MALFORMATION
Clinical Genetics 2000; 58(4): 336-8
A – Factor impacto JCR: 3,578 – Q2 Genetics& Heredity

• Rodríguez A, Fernández Cebrián S, Pérez Muñuzuri A, Martinón-Torres F, Eiris Puñal J, Martinón-Sánchez JM.
CEREBRAL SYNCOPE IN CHILDREN
Journal of Pediatrics 2000, 136(4):542-4.
A – Factor impacto JCR: 3,700 – Q1 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Pérez Muñuzuri A, Monasterios corral L, Alonso Martín A.
TORTICOLIS PERSISTENTE
Anales Españoles de Pediatría 2000; 53(2):161-2.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Pérez Muñuzuri A, Fernández Cebrián S, Castro-Gago M.
INSUFICIENCIA RESPIRATORIA AGUDA
Anales Españoles de Pediatría 2000; 53(6):599-600.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Martinón-Sánchez JM, Pérez Muñuzuri A, Bravo Mata M, MartinónSanchez F.
ERITEMA FIGURADO TIPO PROFUNDO
Anales Españoles de Pediatría 2000; 53(4):380-2.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, RodríguezNúñez A, Jaimovich DG, Martinón Sánchez JM.
VENTILACION DE ALTA FRECUENCIA OSCILATORIA EN PACIENTES PEDIÁTRICOS: PROTOCOLO DE APLICACIÓN Y RESULTADOS PRELIMINARES
Anales Españoles de Pediatría 2000; 53(4):305-13.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Pérez Muñuzuri, Fernández S, Alonso Martín A.
ALTERACIONES RADIOGRAFICAS DE LA CORTICAL OSEA
Anales Españoles de Pediatría 2000; 52(1):67-68.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Rodríguez Núñez A, Martinón Sánchez JM.
HELIOX: PERSPECTIVAS DE APLICACIÓN EN PEDIATRIA
Anales Españoles de Pediatría 1999, supl. 128: 42-45
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Rodríguez Núñez A, Martinón-Torres F, Martinón Sánchez JM.
EMPLEO DE CORTICOIDES Y BRONCODILATADORES EN EL LACTANTE CON BRONQUIOLITIS
Anales Españoles de Pediatría 1999, 128: 24-26
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Fernández Cebrián S, Picón Cotos M, Alonso Martín A.
TUMEFACCION MAXILAR BILATERAL
Anales Españoles de Pediatría 1999; 50(2): 187-8
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Couce Pico ML, Castiñeiras DE, Alonso-Fernández JR, Fraga JM.
DEFICIENCIA DE BIOTINIDASA: IMPORTANCIA DE SU DIAGNÓSTICO NEONATAL Y TRATAMIENTO PRECOZ
Anales Españoles de Pediatría 1999; 50(5):504-6.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Magariños MM, Picón M, Fernández Seara MJ, RodríguezNúñez A, Martinón Sánchez JM.
ENCEFALOPATIA AGUDA AUTOLIMITADA EN RELACION CON EL COMPONENTE ANTISARAMPIONOSO DE LA VACUNA TRIPLE VIRICA
Revista de Neurología 1999, 28(9):881-2
A – Factor impacto JCR: 0,562 – Q4 – ClinicalNeurology

• Martinón-Torres F, Martinón-Sánchez JM, Martinón-Sánchez F.
LOCALIZED GRANULOMA ANNULARE IN CHILDREN: A REVIEW OF 42 CASES
European Journal of Pediatrics 1999, 158 (10):866
A – Factor Impacto JCR: 2,305 – Q2: Pediatrics

• Martinón-Torres F, Fernández Seara MJ, Del Rio Pastoriza I, Bravo Mata M, Castro-Gago M.
PARVOVIRUS B19 INFECTION COMPLICATED BY PERIPHERAL FACIAL PALSY AND PAROTITIS WITH INTRA-PAROTID LYMPHADENITIS
Pediatric Infectious Disease Journal 1999, 18(3):307-8.
A – Factor Impacto JCR: 2,126– Q2 – Immunology

• Martinón Sánchez JM, Martinón-Torres F, RodríguezNúñez AR, Martín MD, Rial Lobatón C.
EL TRANSPORTE PEDIÁTRICO MEDICALIZADO COMO UN “CONTINUUN” EN LA ASISTENCIA A LA URGENCIA VITAL
Anales Españoles de Pediatría 1999, 129:19-22.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Fernández Seara MJ, Del Rio Pastoriza I, Rodrigo Saez E, Martinón Sánchez JM, Castro-Gago M.
CLORODIARREA CONGENITA: TRATAMIENTO COADYUVANTE CON IBUPROFENO Y RANITIDINA
Anales Españoles de Pediatría 1999, 50(6):619-22.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Fernández Cebrián S, Picón cotos M, Alonso Martín A.
ABDOMEN AGUDO
Anales Españoles de Pediatría 1999; 51(3):303-4.
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Eirís J, Rodríguez Núñez A, Donsión M, Fuster M, Martinón-Torres F, Castro-Gago M
EL TILT-TEST COMO MÉTODO ÚTIL EN EL DIAGNÓSTICO DIFERENCIAL ENTRE CRISIS SINCOPALES Y EPILÉPTICAS EN LA INFANCIA
Rev Neurol; 1999; Vol 29: 550
A – Factor impacto JCR: 0,562- Q4 – Clinical Neurology

• I. del Río Pastoriza, F. Martinón-Torres, M. Picón Cotos, S. Fernández Cebrian, F. Álvez González
SÍNDROME DE LA PIEL ESCALDADA ESTAFILOCOCICA: REVISION DE 3 CASOS
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• M. Picón Cotos, S. Fernández Cebrián, I. del Río Pastoriza, F. Martinón-Torres, E. Rodrigo Sáez
SOSPECHA DE MALOS TRATOS EN UN LACTANTE E INFECCIÓN POR VIRUS EPSTEIN-BARR
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• M. Picón Cotos, I. del Río Pastoriza, S. Fernández Cebrián, F. Martinón-Torres, M. J. Fernández Seara
HIPERBILIRRUBINEMIA, ANEMIA Y DOLOR ABDOMINAL. PRESENTACIÓN DE UNA ESFEROCITOSIS HEREDITARIA
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• M. Picón Cotos, S. Fernández Cebrián, I. del Río Pastoriza, F. Martinón-Torres, I. Martínez Soto, J. R. Fernández Lorenzo, J.M. Fraga Bermúdez
SÍNDROME PROGEROIDE NEONATAL
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• I. del Río Pastoriza, F. Martinón Torres, M. Picón Cotos, S. Fernández Cebrian, I. Martínez Soto
LINFANGIECTASIA PULMONAR QUISTICA: A PROPOSITO DE UN CASO
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• F. Martinón Torres, M. Picón Cotos, S. Fernández Cebrián, I. del Río Pastoriza, A. Rodríguez Núñez, J.M. Martinón Sánchez
ENCEFALOPATÍA AGUDA AUTOLIMITADA EN RELACIÓN CON EL COMPONENTE ANTISARAMPIONOSO DE LA VACUNA TRIPLE VIRICA
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• S. Fernández Cebrián, F. Martinón Torres, M. Picón Cotos, I. del Río Pastoriza, A. Rodríguez Núñez, J.M. Martinón Sánchez
¿CUÁL ES EL PAPEL DE LA HIPERVENTILACIÓN EN LA FISIOPATOLOGÍA DEL SINCOPE?
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• S. Fernández Cebrián, F. Martinón Torres, A. Pérez Muñuzuri, A. Rodríguez Núñez, J. Eirís Puñal, J.M. Martinón Sánchez
SÍNCOPE CEREBRAL EN LA INFANCIA
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• A. Pérez Muñuzuri, F. Martinón Torres, A. Bretón Peña, S. Fernández Cebrián, A. Rodríguez Núñez, J.M. Martinón Sánchez
PREVENCION DE LAS COMPLICACIONES INFECCIOSAS DE LOS CATETERES VENOSOS CENTRALES: INFLUENCIA DE LA IRRIGACIÓN CON HEPARINA
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• M. Picón Cotos, F. Martinón Torres, S. Fernández Cebrián, I. del Río Pastoriza, A. Rodríguez Núñez, J.M. Martinón Sánchez
DESTREZA EN EL CÁLCULO DE DOSIFICACIONES DE FARMACOS EN PEDIATRÍA
Anales Españoles de Pediatría 1999; Suplemento 131
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• F. Martinón-Torres, I. del Rio Pastoriza, J. Barreiro Conde, M. Bravo Mata, S. Fernández Cebrian, A. Rodríguez Núñez, J.M. Martinón Sánchez
SÍNDROME HIPOTALAMICO IDIOPATICO. MANIFESTACIONES CLINICAS Y OPCIONES TERAPEUTICAS
Anales Españoles de Pediatría 1999; Suplemento 128: 75
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Fernández S, Muñuzuri AP, Alonso A.
EPILEPSIA REFRACTARIA
Anales Españoles de Pediatría 1999; 51(5):549-50
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Bravo Mata M, Martinón-Torres F, Fernández S, Rodríguez Núñez A, Peleteiro Fernández M, Alonso Martín A.
SÍNDROME DE PICKWICK: POTENCIALMENTE LETAL
Anales Españoles de Pediatría 1998; 49(1): 81-4
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• Martinón-Torres F, Rodríguez Núñez A, Pekarikova J, Martinón-Sánchez JM.
IS HEPARIN DAILY FLUSHING USEFUL TO DECREASE THE INCIDENCE OF CATHETER-RELATED INFECTIONS?
Chest 1998, 114(5):1498-9.
L – Factor Impacto JCR: 8,308 – D1 – Critical Care Medicine

• Rodríguez Núñez A, Martinón-Torres F
NUEVOS MÉTODOS DE ADMINISTRACIÓN DE ANALGESICOS EN LA INFANCIA
Anales Españoles de Pediatría 1998; 120: 424-426
A – Factor Impacto JCR: 1,313 – Q3 – Pediatrics

• García Rodríguez C, Martinón-Torres F, González Borrajo JM, Lomba Otero S, Martinón Sánchez JM
PROPUESTA DE INFORMATIZACIÓN DE LOS INFORMES ENDOSCOPICOS DIGESTIVOS EN PEDIATRÍA
AnPediatr. 11 Mayo 1996; Supl 76: 57
A – Factor Impacto JCR: 1,313 – Q3 – Pediatría